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1. Materials and Methods 
 Unless otherwise stated, reactions were performed under a nitrogen atmosphere using 
freshly dried solvents. Methylene chloride (CH2Cl2), diethyl ether (Et2O), tetrahydrofuran (THF), 
and 1,4-dioxane were dried by passing through activated alumina columns. Ethyl trichloroacetate 
(Sigma Aldrich 163155) was distilled prior to use and stored in a Schlenk tube under an atmosphere 
of nitrogen. Triethylamine (Et3N) was distilled over calcium hydride prior to use. Selectfluor was 
used as received, and was stored in the freezer of a nitrogen-filled glovebox. Dimethyl 2,2-
dichloromalonate was prepared according to literature procedure.1 All other commercially 
obtained reagents were used as received unless specifically indicated. Halogenation reactions were 
performed in a Hepatochem EvoluChemTM PhotoRedOx Box device and irradiated with a Kessil 
A160WE blue LED lamp. Cooling with the internal fan afforded reaction temperatures of 27 °C, 
as measured with a thermocouple. Unless otherwise stated, reactions were stirred at a rate of 430 
rpm. Reaction screens in 1 dram vials were performed with a Biotage 355543 stir bar, while those 
in a ½ dram vial utilized a V&P Scientific VP 774-7 stir bar. Chlorination reactions in 20 mL 
scintillation vials were performed with an egg-shaped stir bar (VWR 58949-010). Bromination 
and fluorination reactions in 20 mL scintillation vials were performed with a “+”-shaped stir bar 
(VWR 58947-822) for better stirring with added Cs2CO3. All reactions were monitored by thin-
layer chromatography using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm). Silica 
gel column chromatography was performed as described by Still et al. (W. C. Still, M. Kahn, A. 
Mitra, J. Org. Chem. 1978, 43, 2923–2925) using silica gel (particle size 0.032–0.063) purchased 
from Silicycle. 1H and 13C NMR spectra were recorded on a Varian Inova 500 (at 500 MHz and 
125 MHz respectively) or a Bruker Avance III HD with Prodigy cyroprobe (at 400 MHz and 101 
MHz respectively). NMR data is reported relative to internal chloroform, DMSO, or methanol 
solvent peaks (with respect to TMS (tetramethylsilane)): CDCl3, 1H, δ = 7.26, 13C, δ = 77.16; 
DMSO-d6, 1H, δ = 2.50, 13C, δ = 39.52; CD3OD, 1H, δ = 3.31, 13C, δ = 49.00). NMR data in D2O 
is reported relative to DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid): D2O, 1H, δ = 4.79. 19F 
spectra were recorded on a Varian 400 MR spectrometer (at 376 MHz); chemical shifts are 
reported in parts per million and are referenced to CFCl3 (δ 0 ppm). NMR data are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicity 
and qualifier abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad. IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and 
are reported in frequency of absorption (cm–1). HRMS were acquired using either an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source using electrospray ionization (ESI) or 
from the Caltech Mass Spectral Facility using electrospray ionization (ESI), electron ionization 
(EI), or fast atom bombardment (FAB). GC-Flame ionization detection analysis was performed on 
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a Agilent Technologies 6850 Network GC system using a Agilent HP-1 capillary column (19091Z-
413E: length 30 m, diameter 0.320 mm, film 0.25 µm). 
 
Abbreviations used: Et2O – diethyl ether; PhMe – toluene; EtOAc – ethyl acetate; THF – 
tetrahydrofuran; Et3N – triethylamine; DMAP – 4-dimethylaminopyridine; ETCA – ethyl 
trichloroacetate. 
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2. Substrate Preparation 
 
Known cesium oxalates: Substrates 1a, 1e, 1i, 1j, and 1l were prepared according to literature 
procedures and the NMR data were consistent with those reported in the literature.2 
 
a. Preparation of cesium 2-((1-(2-(1,3-dioxan-2-yl)ethyl)cyclopentyl)oxy)-2-oxoacetate (1b) 
 
 
1-(2-(1,3-dioxan-2-yl)ethyl)cyclopentan-1-ol (SI-2): A flame-dried 25 mL round bottom flask 
was charged with cyclopentanone (100 mg, 1.19 mmol) and put under an atmosphere of argon. A 
solution of CeCl3•2LiCl3 (4 mL, 1.19 mmol, 0.3 M in THF, 1.0 equiv) was added at 23 °C, and 
the pale yellow mixture stirred for 1 h. The mixture was then cooled to 0 °C and Grignard SI-14 
(3.2 mL, 1.19 mmol, 0.37 M in THF, 1.0 equiv) was added dropwise. After 15 min, TLC analysis 
indicated full conversion, and the mixture was quenched with a saturated aqueous solution of 
NH4Cl (3 mL) and stirred at 0 °C for 5 min. H2O (7 mL) and EtOAc (5 mL) were added and the 
mixture warmed to room temperature and transferred to a separatory funnel. A saturated aqueous 
solution of Rochelle’s salt (10 mL) was added, after which the aqueous layer was extracted with 
EtOAc (4 x 15 mL). The combined organic layers were washed with a saturated aqueous solution 
of NaCl (1 x 15 mL), and the aqueous layer back-extracted with EtOAc (1 x 10 mL). The combined 
organic extracts were dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
crude residue was purified by silica gel chromatography (5–50% EtOAc/hexanes) to afford tertiary 
alcohol SI-2 (195 mg, 82% yield) as a clear oil.  
TLC Rf = 0.32 (50% EtOAc/hexanes, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 4.58 (t, J = 4.6 Hz, 1H), 4.11 (ddt, J = 10.5, 5.0, 1.2 Hz, 2H), 3.83 
– 3.72 (m, 2H), 2.15 – 2.01 (m, 1H), 2.08 (s, 1H), 1.78 (dddd, J = 7.6, 5.6, 4.5, 1.7 Hz, 4H), 1.71 
(ddd, J = 8.3, 6.1, 1.8 Hz, 2H), 1.68 – 1.57 (m, 4H), 1.57 – 1.48 (m, 2H), 1.34 (dtt, J = 13.5, 2.5, 
1.3 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 102.5, 81.8, 66.9, 39.7, 35.4, 30.8, 25.7, 23.8. 
FTIR (NaCl, thin film, cm-1): 3450, 2959, 2852, 1378, 1240, 1145, 994. 
SI-2
2)
82% yield
O
OBrMg
O HO
O
O
1) CeCl3•2LiCl
     THF, 23 °C
THF, 0 °C
SI-1
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HRMS (EI, m/z): calc’d for C11H20O3 (M+×)+: 200.1413, found: 200.1411. 
 
 
1-(2-(1,3-dioxan-2-yl)ethyl)cyclopentyl methyl oxalate (SI-3): To a 50 mL round bottom flask 
containing a solution of alcohol SI-2 (146 mg, 0.73 mmol) in CH2Cl2 (6.6 mL) at 0 °C was added 
Et3N (150 µL, 1.09 mmol, 1.5 equiv), DMAP (9 mg, 0.073 mmol, 0.1 equiv), and methyl oxalyl 
chloride (80 µL, 1.17 mmol, 1.2 equiv) dropwise by syringe. The reaction was stirred at room 
temperature for 2.5 h followed by the addition of H2O (4 mL). The organic layer was collected and 
the aqueous layer was extracted with CH2Cl2 (4 x 6 mL). The combined organic extracts were 
washed with a saturated aqueous solution of NaCl (2 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The crude residue was purified by silica gel chromatography 
(10–33% EtOAc/hexanes) to afford methyl oxalate SI-3 (193 mg, 92% yield) as a clear colorless 
oil.  
TLC Rf = 0.27 (20% EtOAc/hexanes, p-anisaldehyde). 
1H NMR (500 MHz, CDCl3) δ 4.48 (t, J = 5.2 Hz, 1H), 4.07 (ddt, J = 10.5, 5.0, 1.4 Hz, 2H), 3.84 
(s, 3H), 3.72 (dddd, J = 11.9, 10.5, 2.6, 1.6 Hz, 2H), 2.25 – 2.15 (m, 2H), 2.14 – 2.08 (m, 2H), 2.08 
– 1.99 (m, 1H), 1.80 – 1.69 (m, 4H), 1.67 – 1.57 (m, 4H), 1.32 (dtt, J = 13.5, 2.7, 1.4 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 159.0, 157.0, 102.0, 97.1, 67.0, 53.4, 37.4, 31.1, 30.3, 25.9, 24.0.  
FTIR (NaCl, thin film, cm-1): 2960, 2853, 2733, 2658, 1766, 1739, 1454, 1332, 1202, 1146, 1079, 
997. 
HRMS (FAB+, m/z): calc’d for C14H21O6 (M+H–H2)+: 285.1338, found: 285.1317. 
 
  
cesium 2-((1-(2-(1,3-dioxan-2-yl)ethyl)cyclopentyl)oxy)-2-oxoacetate (1b): A 20 mL 
scintillation vial was charged with methyl oxalate SI-3 (119 mg, 0.42 mmol), THF (2.6 mL), and 
SI-2
HO
O
O
CH2Cl2, 0 to 23 °C
Cl
O
O
OMe
92% yield SI-3
O
O
O
O
O
MeO
Et3N, DMAP
THF, H2O, 23 °C
89% yield
CsOH (1 M aq)
SI-3
O
O
O
O
O
MeO
1b
O
O
O
O
O
CsO
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H2O (0.27 mL). A 1 M aqueous solution of CsOH (0.420 mL, 0.42 mmol, 1.0 equiv) was then 
added dropwise to the solution with vigorous stirring. After the addition was complete, the solution 
was stirred for an additional 5 min. The reaction was concentrated under reduced pressure to 
remove the THF and the aqueous layer was washed 1:1 pentane/Et2O (4 x 2 mL). The aqueous 
layer was then concentrated using rotary evaporation followed by high vacuum (~50 mTorr) to 
deliver cesium oxalate 1b as a white amorphous solid (149 mg, 89% yield). 
1H NMR (400 MHz, CD3OD) δ 4.54 (t, J = 5.1 Hz, 1H), 4.03 (ddt, J = 10.4, 4.9, 1.4 Hz, 2H), 3.83 
– 3.69 (m, 2H), 2.28 – 2.13 (m, 2H), 2.12 – 2.05 (m, 2H), 1.98 (dtt, J = 13.4, 12.5, 5.0 Hz, 1H), 
1.84 – 1.67 (m, 4H), 1.67 – 1.53 (m, 4H), 1.34 (dtt, J = 13.4, 2.7, 1.4 Hz, 1H). 
13C NMR (101 MHz, CD3OD) δ 166.3, 166.1, 103.4, 94.9, 67.8, 38.5, 32.3, 31.3, 27.0, 24.9. 
FTIR (NaCl, thin film, cm-1): 2960, 2856, 1715, 1645, 1455, 1404, 1200, 1145, 1078, 995. 
HRMS (TOF-ESI, m/z): calc’d for C13H19O6– (M–Cs)–: 271.1187, found: 271.1187. 
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b. Preparation of cesium cis-2-((1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl)oxy)-2-
oxoacetate (1c) 
 
  
cis-1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexan-1-ol (SI-4) and trans-1-(2-(1,3-
dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexan-1-ol (SI-5): A flame-dried 100 mL round bottom 
flask was charged with 4-tert-butylcyclohexanone (306 mg, 1.98 mmol) and placed under an 
atmosphere of argon. A solution of CeCl3•2LiCl3 (6.6 mL, 1.98 mmol, 0.3 M in THF, 1.0 equiv) 
was added at room temperature and the pale yellow solution was stirred for 1 h. The mixture was 
then cooled to 0 ºC and a solution of Grignard reagent SI-14 (5.0 mL, 2.18 mmol, 0.44 M in THF, 
1.1 equiv) was added dropwise. The reaction was stirred at 0 °C for 1 h. A saturated aqueous 
solution of NH4Cl (10 mL) was added and the reaction was stirred for 25 min while warming to 
room temperature. A saturated aqueous solution of Rochelle’s salt (5 mL) was added and the 
aqueous layer was extracted with Et2O (3 x 12 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude residue was purified by 
silica gel chromatography (10–50% EtOAc/hexanes) to afford alcohol SI-4 (295 mg, 55% yield) 
as a white solid and alcohol SI-5 (60 mg, 11% yield) as a white solid.  
cis-1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexan-1-ol (SI-4): 
TLC Rf = 0.31 (40% EtOAc/hexanes, KMnO4). 
1H NMR (500 MHz, CDCl3) δ 4.53 (t, J = 4.9 Hz, 1H), 4.08 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.74 
(dddd, J = 11.9, 10.5, 2.6, 1.6 Hz, 2H), 2.06 (dtt, J = 13.5, 12.5, 5.0 Hz, 1H), 1.88 (br s, 1H), 1.78 
– 1.61 (m, 4H), 1.60 – 1.42 (m, 4H), 1.40 – 1.16 (m, 5H), 0.99 – 0.86 (m, 1H), 0.83 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 102.8, 69.9, 67.0, 48.1, 38.0, 37.7, 32.5, 29.1, 27.7, 25.8, 22.6. 
FTIR (NaCl, thin film, cm-1): 3481, 2949, 2847, 2732, 2654, 1456, 1432, 1402, 1365, 1242, 1145, 
1073, 1006, 979. 
HRMS (FAB+, m/z): calc’d for C16H29O3 (M+H–H2)+: 269.2117, found: 269.2095. 
 
trans-1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexan-1-ol (SI-5): 
TLC Rf = 0.18 (40% EtOAc/hexanes, KMnO4). 
SI-4
55% yield SI-4
11% yield SI-5
2)
O
OBrMg
1) CeCl3•2LiCl
    THF, 23 °C
THF, 0 °C
SI-1
SI-5
+
tBu
HO
O
O
tBu
HO
O
O
tBu
O
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1H NMR (400 MHz, CDCl3) δ 4.56 (t, J = 4.7 Hz, 1H), 4.10 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.76 
(dddd, J = 11.9, 10.5, 2.6, 1.6 Hz, 2H), 2.17 (br s, J = 3.4 Hz, 1H), 2.08 (dtt, J = 13.5, 12.5, 5.0 
Hz, 1H), 1.77 (ddd, J = 13.8, 3.9, 2.2 Hz, 2H), 1.74 – 1.58 (m, 6H), 1.42 – 1.30 (m, 3H), 1.12 – 
0.98 (m, 3H), 0.84 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 102.8, 71.5, 67.0, 47.7, 38.8, 32.4, 30.3, 28.8, 27.8, 25.8, 24.5. 
FTIR (NaCl, thin film, cm-1): 3296, 2941, 2863, 2729, 2656, 1455, 1365, 1283, 1239, 1211, 1148, 
1102, 1007, 984. 
HRMS (FAB+, m/z): calc’d for C16H29O3 (M+H–H2)+: 269.2117, found: 269.2123. 
 
 
cis-1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl methyl oxalate (SI-6): To a 50 mL 
round bottom flask containing a solution of alcohol SI-4 (231 mg, 0.85 mmol) in CH2Cl2 (7.8 mL) 
at 0 °C was added Et3N (0.18 mL, 1.28 mmol, 1.5 equiv), DMAP (10 mg, 0.09 mmol, 0.1 equiv), 
and methyl oxalyl chloride (0.09 mL, 1.03 mmol, 1.2 equiv) dropwise via syringe. The reaction 
was stirred at room temperature for 3 h followed by the addition of a 1:1 mixture of a saturated 
aqueous solution of NaCl and H2O (3 mL). The organic layer was collected and the aqueous layer 
was extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The crude residue was purified by silica gel 
chromatography (10–20% EtOAc/hexanes) to give methyl oxalate SI-6 (301 mg, 99% yield) as a 
pale yellow oil.  
TLC Rf = 0.56 (40% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 4.47 (t, J = 5.2 Hz, 1H), 4.07 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.85 
(s, 3H), 3.72 (dddd, J = 11.9, 10.5, 2.6, 1.6 Hz, 2H), 2.49 – 2.37 (m, 2H), 2.13 – 1.95 (m, 3H), 1.68 
– 1.51 (m, 4H), 1.40 – 1.16 (m, 6H), 1.09 – 0.94 (m, 1H), 0.83 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ 159.1, 156.7, 102.2, 88.1, 67.0, 53.3, 47.2, 34.6, 32.5, 32.4, 29.1, 
27.6, 25.9, 22.3. 
FTIR (NaCl, thin film, cm-1): 2954, 2866, 2732, 2658, 1767, 1740, 1453, 1366, 1331, 1205, 1165, 
1004, 977. 
HRMS (FAB+, m/z): calc’d for C19H31O6 (M+H–H2)+: 355.2121, found: 355.2133. 
 
SI-4
99% yield
SI-6
tBu
O
O
O
O
MeO
O
tBu
HO
O
O
CH2Cl2, 0 to 23 °C
Cl
O
O
OMe
Et3N, DMAP
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cesium cis-2-((1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl)oxy)-2-oxoacetate (1c): A 
20 mL scintillation vial was charged with methyl oxalate SI-6 (118 mg, 0.33 mmol), THF (2.1 
mL), and H2O (0.22 mL). A 1 M aqueous solution of CsOH (0.33 mL, 0.33 mmol, 1.0 equiv) was 
then added dropwise to the solution with vigorous stirring. After the addition was complete, the 
mixture was stirred for an additional 5 min. The reaction was then concentrated under reduced 
pressure to remove the THF and the aqueous layer was washed with 1:1 pentane/Et2O (4 x 2 mL). 
The aqueous layer was then concentrated under reduced pressure using rotary evaporation 
followed by high vacuum (~50 mTorr) to afford cesium oxalate 1c as a white solid (141 mg, 90% 
yield). 
1H NMR (400 MHz, CD3OD) δ 4.51 (t, J = 5.1 Hz, 1H), 4.02 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.83 
– 3.69 (m, 2H), 2.52 – 2.39 (m, 2H), 2.04 – 1.91 (m, 3H), 1.67 – 1.52 (m, 4H), 1.46 – 1.30 (m, 
3H), 1.24 (td, J = 13.5, 3.6 Hz, 2H), 1.04 (tt, J = 12.0, 3.3 Hz, 1H), 0.86 (s, 9H). 
13C NMR (101 MHz, CD3OD) δ 166.4, 166.1, 103.6, 85.4, 67.8, 35.8, 33.6, 33.2, 30.1, 28.0, 27.0, 
23.4. 
FTIR (NaCl, thin film, cm-1): 2952, 2851, 2734, 1704, 1622, 1452, 1399, 1212, 1147, 979. 
HRMS (TOF-ESI, m/z): calc’d for C18H29O6– (M–Cs)–: 341.1970, found: 341.1974. 
 
  
SI-6 1c
89% yield tBu
O
O
O
O
CsO
O
tBu
O
O
O
O
MeO
O
THF, H2O, 23 °C
CsOH (1 M aq)
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c. Preparation of cesium trans-2-((1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl)oxy)-
2-oxoacetate (1c’) 
 
trans-1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl methyl oxalate (SI-7): To a 50 mL 
round bottom flask containing a solution of alcohol SI-5 (136 mg, 0.50 mmol) in CH2Cl2 (4.6 mL) 
at 0 °C was added Et3N (0.11 mL, 0.75 mmol, 1.5 equiv), DMAP (6 mg, 0.05 mmol, 0.1 equiv), 
and methyl oxalyl chloride (0.06 mL, 0.60 mmol, 1.2 equiv) dropwise via syringe. The reaction 
was stirred at room temperature for 3 h followed by the addition of a 1:1 mixture of saturated 
aqueous NaCl and H2O (2 mL). The organic layer was collected and the aqueous layer was 
extracted with CH2Cl2 (4 x 4 mL). The combined organic extracts were dried over MgSO4, filtered, 
and concentrated under reduced pressure. The crude residue was purified by silica gel 
chromatography (10–20% EtOAc/hexanes) to furnish methyl oxalate SI-7 (159 mg, 88% yield) as 
a clear colorless oil.  
TLC Rf = 0.54 (40% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 4.49 (t, J = 5.2 Hz, 1H), 4.07 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.83 
(s, 3H), 3.73 (dddd, J = 11.9, 10.4, 2.6, 1.6 Hz, 2H), 2.33 – 2.19 (m, 2H), 2.14 – 1.96 (m, 3H), 1.82 
– 1.66 (m, 4H), 1.66 – 1.52 (m, 2H), 1.32 (dtt, J = 13.5, 2.7, 1.4 Hz, 1H), 1.26 – 1.02 (m, 3H), 0.83 
(s, 9H). 
13C NMR (101 MHz, CDCl3) δ 159.0, 156.6, 102.2, 90.0, 67.0, 53.4, 47.3, 34.6, 32.3, 28.8, 27.7, 
26.4, 25.9, 24.1. 
FTIR (NaCl, thin film, cm-1): 2954, 2868, 2731, 2658, 1767, 1740, 1461, 1367, 1326, 1206, 1166, 
1093, 1010, 973. 
HRMS (FAB+, m/z): calc’d for C19H31O6 (M+H–H2)+: 355.2121, found: 355.2133. 
 
SI-5 SI-7
tBu
O
O
O
O
MeO
O
tBu
HO
O
O
88% yield
CH2Cl2, 0 to 23 °C
Cl
O
O
OMe
Et3N, DMAP
  S11 
 
cesium trans-2-((1-(2-(1,3-dioxan-2-yl)ethyl)-4-(tert-butyl)cyclohexyl)oxy)-2-oxoacetate 
(1c’): A 20 mL scintillation vial was charged with methyl oxalate SI-7 (118 mg, 0.33 mmol), THF 
(2.1 mL), and H2O (0.22 mL). A 1 M aqueous solution of CsOH (1 M in H2O, 0.33 mL, 0.33 
mmol, 1.0 equiv) was added dropwise to the solution with vigorous stirring. After the addition was 
complete, the mixture was stirred for an additional 5 min. The reaction was concentrated under 
reduced pressure to remove the THF and the aqueous layer was washed with 1:1 pentane/Et2O (4 
x 2 mL). The aqueous layer was concentrated under reduced pressure using rotary evaporation 
followed by high vacuum (~50 mTorr) to afford cesium oxalate 1c’ as a white solid (129 mg, 82% 
yield). 
1H NMR (400 MHz, CD3OD) δ 4.56 (t, J = 5.2 Hz, 1H), 4.04 (ddt, J = 10.5, 5.1, 1.4 Hz, 2H), 3.78 
(dddd, J = 12.0, 10.5, 2.6, 1.6 Hz, 2H), 2.36 – 2.26 (m, 2H), 2.15 – 2.07 (m, 2H), 2.00 (dtt, J = 
13.4, 12.5, 5.0 Hz, 1H), 1.71 (td, J = 11.5, 5.9 Hz, 4H), 1.64 – 1.52 (m, 2H), 1.35 (dtt, J = 13.4, 
2.6, 1.4 Hz, 1H), 1.24 – 1.06 (m, 3H), 0.88 (s, 9H). 
13C NMR (101 MHz, CD3OD) δ 166.5, 165.9, 103.6, 87.2, 67.9, 35.9, 33.0, 29.8, 28.0, 27.2, 27.0, 
25.0. 
FTIR (NaCl, thin film, cm-1): 2952, 2867, 2732, 2662, 1713, 1645, 1462, 1373, 1210, 1146, 1091, 
1006, 972. 
HRMS (TOF-ESI, m/z): calc’d for C18H29O6– (M–Cs)–: 341.1970, found: 341.1972. 
 
  
SI-7 1c’
tBu
O
O
O
O
CsO
O
tBu
O
O
O
O
MeO
O
82% yield
THF, H2O, 23 °C
CsOH (1 M aq)
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d. Preparation of cesium 2-(((1R,4aR,8aS)-1-(2-(1,3-dioxan-2-
yl)ethyl)decahydronaphthalen-1-yl)oxy)-2-oxoacetate (1d) 
 
 
(1R,4aR,8aS)-1-(2-(1,3-dioxan-2-yl)ethyl)decahydronaphthalen-1-ol (SI-8): A flame-dried 50 
mL round bottom flask was charged with trans-decalone (500 mg, 3.28 mmol) and put under an 
atmosphere of nitrogen. THF (3.3 mL) was added, followed by dropwise addition of a solution of 
Grignard reagent SI-14 (8.2 mL, 1.25 mmol, 0.5 M in THF, 1.25 equiv) at 23 °C. TLC analysis 
indicated full conversion after 2 h, and the mixture was quenched with a saturated aqueous solution 
of NH4Cl (5 mL) and stirred vigorously for 10 min. The biphasic mixture was concentrated under 
rotary evaporation to remove the THF. A saturated aqueous solution of NaCl (3 mL) was added 
and the resulting solution was extracted with EtOAc (4 x 15 mL). The combined organic extracts 
were dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The crude 
residue was purified by silica gel chromatography (0–40% EtOAc/hexanes) to provide tertiary 
alcohol SI-8 (553 mg, 63% yield) as a white solid.  
TLC Rf = 0.31 (33% EtOAc/hexanes, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 4.50 (t, J = 4.7 Hz, 1H), 4.09 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.75 
(td, J = 12.3, 2.5 Hz, 2H), 2.07 (dtt, J = 13.5, 12.4, 5.0 Hz, 1H), 1.81 – 1.71 (m, 2H), 1.60 (dddd, 
J = 19.4, 10.4, 4.6, 2.5 Hz, 7H), 1.55 – 1.46 (m, 3H), 1.39 – 1.25 (m, 3H), 1.19 (tdd, J = 8.8, 4.2, 
2.5 Hz, 2H), 1.13 – 1.01 (m, 1H), 0.98 – 0.82 (m, 3H). 
13C NMR (101 MHz, CDCl3) δ 102.8, 72.4, 67.1, 49.0, 37.2, 36.7, 34.8, 34.6, 34.3, 29.7, 26.9, 
26.3, 25.9, 24.9, 21.3. 
FTIR (NaCl, thin film, cm-1): 3495, 2925, 2849, 1448, 1377, 1145, 999. 
HRMS (EI, m/z): calc’d for C16H28O3 (M+×)+: 268.2039, found: 268.2054. 
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(1R,4aR,8aS)-1-(2-(1,3-dioxan-2-yl)ethyl)decahydronaphthalen-1-yl methyl oxalate (SI-9): A 
flame-dried 25 mL round bottom flask was charged with alcohol SI-8 (240 mg, 0.89 mmol) and 
THF (3.6 mL). The flask was cooled to –78 ºC followed by dropwise addition of nBuLi (2.5 M in 
hexanes, 0.46 mL, 1.16 mmol, 1.3 equiv). The reaction was then stirred for an additional 30 min. 
Methyl oxalyl chloride (30 µL, 0.31 mmol, 1.7 equiv) was added dropwise by syringe. The solution 
was stirred at –78 ºC for 30 min and then warmed to room temperature over 2 h. The reaction was 
quenched with a 1:1 mixture of a saturated aqueous solution of NaHCO3 and a saturated aqueous 
solution of NaCl (3 mL). The biphasic mixture was concentrated under rotary evaporation to 
remove the THF and the resulting solution was extracted with EtOAc (4 x 5 mL). The combined 
organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude residue was purified by silica gel chromatography (0–25% EtOAc/hexanes) to afford methyl 
oxalate SI-9 (306 mg, 97% yield) as a viscous yellow oil.  
TLC Rf = 0.35 (15% EtOAc/hexanes, p-anisaldehyde). 
1H NMR (500 MHz, CDCl3) δ 4.47 (t, J = 5.1 Hz, 1H), 4.12 – 4.04 (m, 2H), 3.86 (s, 3H), 3.73 
(tdd, J = 12.0, 5.0, 2.6 Hz, 2H), 2.72 – 2.63 (m, 1H), 2.39 (ddd, J = 13.4, 11.3, 5.8 Hz, 1H), 2.06 
(dtt, J = 13.5, 12.5, 5.0 Hz, 1H), 1.94 – 1.84 (m, 1H), 1.83 – 1.71 (m, 2H), 1.70 – 1.61 (m, 2H), 
1.61 – 1.10 (m, 11H), 1.02 (ddd, J = 11.6, 10.4, 3.0 Hz, 1H), 0.99 – 0.86 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 159.2, 156.8, 102.2, 91.2, 67.02, 66.99, 53.3, 47.8, 36.6, 34.6, 
33.7, 31.9, 30.3, 29.4, 26.7, 26.1, 25.8, 24.7, 21.1. 
FTIR (NaCl, thin film, cm-1): 2931, 2851, 2732, 2662, 1766, 1739, 1450, 1330, 1205, 1170, 1144, 
1002. 
HRMS (FAB+, m/z): calc’d for C19H29O6 (M+H–H2)+: 353.1964, found: 353.1969. 
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cesium 2-(((1R,4aR,8aS)-1-(2-(1,3-dioxan-2-yl)ethyl)decahydronaphthalen-1-yl)oxy)-2-
oxoacetate (1d): A 20 mL scintillation vial was charged with methyl oxalate SI-9 (141 mg, 
0.40 mmol), THF (2.5 mL), and H2O (0.26 mL). A 1 M aqueous solution of CsOH (1 M in H2O, 
0.40 mL, 0.40 mmol, 1.0 equiv) was added dropwise to the solution with vigorous stirring. After 
the addition was complete, the mixture was stirred for an additional 5 min. The reaction was then 
concentrated under reduced pressure to remove the THF and the aqueous layer was washed with 
1:1 pentane/Et2O (4 x 2 mL). The aqueous layer was concentrated under reduced pressure using 
rotary evaporation and then high vacuum (~50 mTorr) to deliver cesium oxalate 1d as a 
hygroscopic white solid (177 mg, 94% yield).  
1H NMR (400 MHz, CD3OD) δ 4.51 (t, J = 5.1 Hz, 1H), 4.04 (ddt, J = 10.5, 5.0, 1.4 Hz, 2H), 3.78 
(dddd, J = 14.6, 10.6, 3.5, 2.0 Hz, 2H), 2.76 – 2.63 (m, 1H), 2.51 – 2.32 (m, 1H), 1.99 (dtt, J = 
13.4, 12.5, 5.0 Hz, 1H), 1.87 (ddd, J = 13.4, 10.2, 7.7 Hz, 1H), 1.82 – 1.70 (m, 2H), 1.69 – 1.14 
(m, 13H), 1.09 – 0.87 (m, 3H). 
13C NMR (101 MHz, CD3OD) δ 167.3, 166.8, 103.5, 88.6, 67.9, 37.5, 35.9, 35.1, 33.2, 31.2, 30.4, 
27.7, 27.2, 27.0, 25.6, 22.1. 
FTIR (NaCl, thin film, cm-1): 2930, 2850, 2732, 2665, 1706, 1632, 1448, 1404, 1217, 1145, 1076, 
1026, 1001. 
HRMS (TOF-ESI, m/z): calc’d for C18H27O6– (M–Cs)–: 339.1813, found: 339.1812. 
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e. Preparation of cesium 2-((7-benzyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)oxy)-2-
oxoacetate (1f) 
 
 
7-benzyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-ol (SI-11): To a 50 mL round bottom flask 
containing a solution of cycloheptanone SI-10 (100 mg, 0.62 mmol)5 in THF (2.5 mL) at 0 °C was 
added a solution of benzylmagnesium chloride (2.0 M in THF, 0.47 mL, 0.94 mmol, 1.5 equiv) 
dropwise. The reaction was stirred at room temperature for 16 h and a saturated aqueous solution 
of NH4Cl (2 mL) was slowly added. The biphasic mixture was concentrated under rotary 
evaporation to remove the THF.  A saturated aqueous solution of NaCl (2 mL) was added and the 
resulting mixture was extracted with Et2O (4 x 5 mL). The combined organic extracts were dried 
over MgSO4, filtered, and concentrated under reduced pressure. The crude residue was purified by 
silica gel chromatography (5–15% EtOAc/hexanes) to furnish tertiary alcohol SI-11 (132 mg, 84% 
yield) as a white solid.  
TLC Rf = 0.23 (10% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.21 (m, 3H), 7.21 – 7.15 (m, 2H), 7.09 (s, 4H), 3.16 (t, J = 
13.3 Hz, 2H), 2.74 (s, 2H), 2.50 (dd, J = 14.6, 7.3 Hz, 2H), 1.80 (dd, J = 14.0, 7.4 Hz, 2H), 1.58 
(t, J = 13.1 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ 142.9, 136.9, 130.9, 128.8, 128.4, 126.7, 126.3, 73.6, 50.8, 39.1, 
29.6. 
FTIR (NaCl, thin film, cm-1): 3557, 3455, 3060, 3026, 2931, 2853, 1493, 1454, 1223, 1086, 1042, 
909. 
HRMS (ESI, m/z): (EI, m/z): calc’d for C18H19O (M+H–H2)+: 251.1436, found: 251.1433. 
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mL) at 0 °C was added Et3N (0.2 mL, 1.46 mmol, 1.5 equiv), DMAP (12 mg, 0.10 mmol, 0.1 
equiv), and methyl oxalyl chloride (0.11 mL, 1.17 mmol, 1.2 equiv) dropwise by syringe. The 
reaction was stirred at room temperature for 4.5 h followed by the addition of a 4:1 mixture of a 
saturated aqueous solution of NH4Cl and a saturated aqueous solution of NaCl (5 mL). The organic 
layer was collected and the aqueous layer was extracted with Et2O (4 x 8 mL). The combined 
organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude residue was purified by silica gel chromatography (5–10% EtOAc/hexanes) to afford methyl 
oxalate SI-12 (297 mg, 90% yield) as a clear crystalline solid.  
TLC Rf = 0.52 (15% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.30 – 7.19 (m, 4H), 7.15 – 7.10 (m, 2H), 7.08 (q, J = 1.2 Hz, 4H), 
3.88 (s, 3H), 3.30 (s, 2H), 3.14 – 2.99 (m, 2H), 2.67 (dd, J = 14.2, 7.3 Hz, 2H), 2.56 (ddd, J = 14.9, 
7.3, 1.3 Hz, 2H), 1.69 – 1.48 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ 159.0, 157.3, 142.1, 135.7, 130.7, 129.0, 128.4, 127.0, 126.5, 91.2, 
53.5, 45.0, 35.9, 29.3. 
FTIR (NaCl, thin film, cm-1): 3028, 2952, 1766, 1738, 1494, 1454, 1326, 1202, 1165, 981. 
HRMS (ESI, m/z): (EI, m/z): calc’d for C21H21O4 (M+H–H2)+: 337.1440, found: 337.1435. 
 
  
cesium 2-((7-benzyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)oxy)-2-oxoacetate (1f): A 
20 mL scintillation vial was charged with methyl oxalate SI-12 (253 mg, 0.75 mmol), THF 
(4.7 mL), and H2O (0.8 mL). A 1 M aqueous solution of CsOH (1 M in H2O, 0.75 mL, 0.75 mmol, 
1.0 equiv) was added dropwise to the solution with vigorous stirring. After the addition was 
complete, the mixture was stirred for an additional 5 min. The reaction was concentrated under 
reduced pressure using rotary evaporation and then high vacuum (~50 mTorr) to provide cesium 
oxalate 1f as a white solid (339 mg, 99% yield). 
1H NMR (400 MHz, DMSO-d6) δ 7.28 – 7.14 (m, 5H), 7.11 – 6.99 (m, 4H), 3.20 (s, 2H), 3.01 (t, 
J = 12.9 Hz, 2H), 2.48 – 2.36 (m, 4H), 1.32 (t, J = 13.1 Hz, 2H). 
13C NMR (101 MHz, DMSO-d6) δ 167.9, 163.3, 142.4, 136.9, 130.7, 128.5, 127.8, 126.2, 126.0, 
83.7, 44.1, 35.8, 28.4. 
IR (ATR, cm-1): 3374, 2965, 1712, 1627, 1396, 1208, 1185. 
HRMS (TOF-ESI, m/z): calc’d for C20H19O4 (M–Cs)–: 323.1289, found: 323.1292. 
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f. Preparation of cesium 2-((7-(2-(1,3-dioxan-2-yl)ethyl)-6,7,8,9-tetrahydro-5H-
benzo[7]annulen-7-yl)oxy)-2-oxoacetate (1g) 
 
  
7-(2-(1,3-dioxan-2-yl)ethyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-ol (SI-13):   
A flame-dried 25 mL round bottom flask was charged with magnesium turnings (99 mg, 4.06 
mmol, 2.6 equiv). The vessel was exchanged three times with argon and THF (1.0 mL) was added.  
With vigorous stirring, 1,2-dibromoethane (35 µL, 0.41 mmol, 0.26 equiv) was added dropwise to 
the suspension. After 10 min, a solution of 2-(2-bromoethyl)-1,3-dioxane (517 mg, 2.65 mmol, 1.7 
equiv) in THF (2.0 mL) was added dropwise over 10 min. Upon completion of addition, the 
reaction was stirred for an additional 1.5 h, yielding a grey solution. A separate flame-dried 50 mL 
round bottom flask was charged with cyclopentanone SI-10 (250 mg, 1.56 mmol)5 and THF 
(2.0 mL) to which the Grignard reagent was added dropwise via syringe. The Grignard reagent 
flask was rinsed with THF (1.0 mL) and added to the reaction for quantitative transfer. The 
resulting solution was stirred for 22 h and then quenched with the addition of a saturated aqueous 
solution of NH4Cl (3 mL) and stirred vigorously for 10 min. The biphasic mixture was 
concentrated under rotary evaporation to remove the THF. A saturated aqueous solution of NaCl 
(2 mL) was added and the resulting solution was extracted with Et2O (4 x 10 mL). The combined 
organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude residue was purified by silica gel chromatography (10–50% EtOAc/hexanes) to give tertiary 
alcohol SI-13 (267 mg, 62% yield) as a clear crystalline solid. 
TLC Rf = 0.34 (50% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.10 (s, 4H), 4.57 (t, J = 4.8 Hz, 1H), 4.12 (ddt, J = 10.5, 5.0, 1.4 
Hz, 2H), 3.83 – 3.66 (m, 2H), 3.18 (t, J = 13.2 Hz, 2H), 2.52 (ddd, J = 14.6, 7.7, 1.4 Hz, 2H), 2.32 
(t, J = 11.3 Hz, 1H), 2.18 – 2.00 (m, 1H), 1.84 (dd, J = 13.9, 7.8 Hz, 2H), 1.75 (dtd, J = 10.6, 5.1, 
2.8 Hz, 2H), 1.61 (dd, J = 8.9, 6.4 Hz, 2H), 1.51 (t, J = 12.9 Hz, 2H), 1.35 (dtt, J = 13.5, 2.6, 1.4 
Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 143.1, 128.8, 126.1, 102.6, 72.9, 67.0, 39.2, 38.0, 29.7, 29.0, 25.8. 
FTIR (NaCl, thin film, cm-1): 3457, 2932, 2853, 1492, 1454, 1404, 1144, 1097, 1014, 998, 903. 
HRMS (EI, m/z): calc’d for C17H23O3 (M+H–H2)+: 275.1647, found: 275.1638. 
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7-(2-(1,3-dioxan-2-yl)ethyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl methyl oxalate (SI-
14): To a 50 mL round bottom flask containing a solution of alcohol SI-13 (202 mg, 0.73 mmol) 
in CH2Cl2 (6.6 mL) at 0 °C was added Et3N (0.15 mL, 1.09 mmol, 1.5 equiv), DMAP (9 mg, 0.07 
mmol, 0.1 equiv), and methyl oxalyl chloride (0.11 mL, 1.17 mmol, 1.2 equiv) dropwise by 
syringe. The reaction was stirred at room temperature for 3 h followed by the addition of a 3:1 
mixture of a saturated aqueous solution of NH4Cl and a saturated aqueous solution of NaCl (4 mL). 
The organic layer was collected and the aqueous layer was extracted with CH2Cl2 (3 x 6 mL). The 
combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced 
pressure. The crude residue was purified by silica gel chromatography (10–33% EtOAc/hexanes) 
to afford methyl oxalate SI-14 (237 mg, 89% yield) as a white crystalline solid.  
TLC Rf = 0.34 (33% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.10 (s, 4H), 4.48 (t, J = 5.1 Hz, 1H), 4.07 (ddt, J = 10.4, 5.0, 1.4 
Hz, 2H), 3.88 (s, 3H), 3.72 (dddd, J = 11.9, 10.5, 2.6, 1.6 Hz, 2H), 3.15 – 2.95 (m, 2H), 2.59 (ddt, 
J = 14.0, 10.5, 6.6 Hz, 4H), 2.15 – 1.94 (m, 3H), 1.72 – 1.43 (m, 4H), 1.32 (dtt, J = 13.4, 2.6, 1.4 
Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 158.9, 156.6, 142.1, 129.0, 126.5, 102.0, 91.2, 67.0, 53.5, 36.0, 
32.9, 29.4, 29.2, 25.8. 
FTIR (NaCl, thin film, cm-1): 2954, 2852, 2732, 1765, 1740, 1494, 1454, 1327, 1206, 1168, 1085, 
1009, 894. 
HRMS (EI, m/z): calc’d for C20H25O6 (M+H–H2)+: 361.1651, found: 361.1652. 
 
  
cesium 2-((7-(2-(1,3-dioxan-2-yl)ethyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)oxy)-2-
oxoacetate (1g): A 20 mL scintillation vial was charged with methyl oxalate SI-14 (180 mg, 0.50 
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mmol), THF (3.1 mL), and H2O (0.53 mL). A 1 M aqueous solution of CsOH (1 M in H2O, 0.5 
mL, 0.50 mmol, 1.0 equiv) was added dropwise to the solution with vigorous stirring. After the 
addition was complete, the mixture was stirred for an additional 5 min. The reaction was 
concentrated under reduced pressure using rotary evaporation and then high vacuum (~50 mTorr) 
to give cesium oxalate 1g as a hygroscopic white solid (242 mg, quant. yield). 
1H NMR (400 MHz, D2O) δ 7.24 – 7.01 (m, 4H), 4.66 (t, J = 5.3 Hz, 1H), 4.05 (ddd, J = 12.2, 5.0, 
1.3 Hz, 2H), 3.83 (td, J = 12.4, 2.4 Hz, 2H), 2.98 (dd, J = 14.6, 11.6 Hz, 2H), 2.56 (dd, J = 14.7, 
7.7 Hz, 2H), 2.47 (dd, J = 14.5, 7.7 Hz, 2H), 2.10 – 1.82 (m, 3H), 1.72 – 1.34 (m, 5H). 
13C NMR (101 MHz, D2O) δ 167.5, 166.5, 145.2, 131.4, 129.1, 104.6, 91.9, 69.5, 38.0, 34.6, 31.1, 
30.9, 27.6. 
IR (ATR, cm-1): 3399, 2933, 2856, 1711, 1638, 1375, 1206, 1145. 
HRMS (TOF-ESI, m/z): calc’d for C19H23O6 (M–Cs)–: 347.1500, found: 347.1503. 
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g. Preparation of cesium 2-((2-((3r,5r,7r)-adamantan-1-yl)-1-phenylpropan-2-yl)oxy)-2-
oxoacetate (1h) 
 
 
2-((3r,5r,7r)-adamantan-1-yl)-1-phenylpropan-2-ol (SI-15): A flame-dried 25 mL round 
bottom flask was charged with ZnCl2 (38 mg, 0.28 mmol, 0.25 equiv) and THF (1.7 mL). A 
solution of BnMgCl (2.0 M in THF, 1.1 mL, 02.24 mmol, 2.0 equiv) was added dropwise and the 
reaction was stirred for 1 h. The contents were then cooled to 0 ºC and a solution of 1-adamantyl 
methyl ketone (200 mg, 1.12 mmol) in THF (2.0 mL) was added dropwise. The reaction was stirred 
for 2 h at 0 ºC then warmed to room temperature over 12 h. A 4:1 mixture of a saturated aqueous 
solution of NH4Cl and H2O (2.5 mL) was slowly added and the biphasic mixture was concentrated 
under rotary evaporation to remove the THF. The resulting solution was extracted with Et2O (4 x 
4 mL). The combined organic extracts were washed with saturated aqueous NaCl (3 mL), dried 
over MgSO4, filtered, and concentrated under reduced pressure. The crude ratio of benzyl adduct 
SI-15 to 1-adamantyl methyl ketone starting material was ~8:1. The crude residue was purified by 
silica gel chromatography (5–10% Et2O/hexanes) to afford tertiary alcohol SI-15 (247 mg, 82% 
yield) as a white solid.  
TLC Rf = 0.36 (15% Et2O/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.15 (m, 5H), 2.92 (d, J = 13.1 Hz, 1H), 2.56 (d, J = 13.1 
Hz, 1H), 2.13 – 1.94 (m, 3H), 1.76 (d, J = 3.1 Hz, 7H), 1.69 (ddt, J = 13.3, 9.4, 2.2 Hz, 5H), 1.13 
– 1.03 (br s, 1H), 0.92 (d, J = 0.9 Hz, 3H).  
13C NMR (101 MHz, CDCl3) δ 138.7, 131.2, 128.1, 126.2, 75.8, 41.1, 39.3, 37.3, 36.4, 28.9, 20.8. 
FTIR (NaCl, thin film, cm-1): 3496, 2905, 2850, 1679, 1492, 1453, 1379, 1345, 1191, 1090, 927. 
HRMS (EI, m/z): calc’d for C19H25O (M+H–H2)+: 269.1905, found: 269.1900. 
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2-((3r,5r,7r)-adamantan-1-yl)-1-phenylpropan-2-yl methyl oxalate (SI-16): A flame-dried 25 
mL round bottom flask was charged with alcohol SI-15 (50 mg, 0.19 mmol) and THF (0.74 mL). 
The flask was cooled to –78 ºC followed by dropwise addition of nBuLi (2.05 M in hexanes, 0.11 
mL, 0.22 mmol, 1.2 equiv). The reaction was stirred for an additional 30 min at the same 
temperature. Methyl oxalyl chloride (30 µL, 0.31 mmol, 1.7 equiv) was added dropwise via 
syringe. The reaction was stirred at –78 ºC for 1 h and then warmed to room temperature over 3 h. 
The reaction was diluted with Et2O (1.5 mL) and quenched with a 1:1 mixture of a saturated 
aqueous solution of NaHCO3 and a saturated aqueous solution of NaCl (2 mL). The biphasic 
mixture was concentrated under rotary evaporation to remove the THF and the resulting solution 
was extracted with Et2O (4 x 3 mL). The combined organic extracts were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The crude residue was purified by silica gel 
chromatography (5–15% Et2O/hexanes) to provide methyl oxalate SI-16 (51 mg, 77% yield) as a 
white crystalline solid.  
TLC Rf = 0.40 (10% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.43 – 7.05 (m, 5H), 3.89 (s, 3H), 3.33 (d, J = 13.6 Hz, 1H), 2.73 
(dd, J = 13.9, 2.6 Hz, 1H), 2.15 – 1.97 (m, 3H), 1.92 – 1.80 (m, 3H), 1.71 (p, J = 12.7, 12.2 Hz, 
9H), 1.48 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 159.3, 156.9, 137.4, 131.1, 128.1, 126.6, 96.0, 53.4, 41.4, 40.9, 
37.0, 36.9, 28.6, 18.6. 
FTIR (NaCl, thin film, cm-1): 3028, 2906, 2850, 1766, 1744, 1604, 1496, 1454, 1323, 1208, 1158, 
984. 
HRMS (EI, m/z): calc’d for C22H27O4 (M+H–H2)+: 355.1909, found: 355.1921. 
 
 
nBuLi
THF, –78 °C
Cl
O
O
OMe
77% yield
SI-15 SI-16
then
–78 to 23 °C
Me
O
Ph
O
OMe
O
Me
OH
Ph
  S22 
  
cesium 2-((2-((3r,5r,7r)-adamantan-1-yl)-1-phenylpropan-2-yl)oxy)-2-oxoacetate (1h): A 20 
mL scintillation vial was charged with methyl oxalate SI-16 (292 mg, 0.82 mmol), THF (5.1 mL), 
and H2O (0.88 mL). A 1 M aqueous solution of CsOH (0.82 mL, 0.82 mmol, 1.0 equiv) was then 
added dropwise with vigorous stirring. After the addition was complete, the mixture was stirred 
for an additional 5 min. The vial was then concentrated under reduced pressure using rotary 
evaporation followed by high vacuum (~50 mTorr) to afford cesium oxalate 1h as a white solid 
(391 mg, quant. yield). 
1H NMR (400 MHz, DMSO-d6) δ 7.39 – 7.26 (m, 2H), 7.26 – 7.08 (m, 3H), 3.16 (d, J = 13.8 Hz, 
1H), 2.79 (d, J = 13.9 Hz, 1H), 2.03 – 1.88 (m, 3H), 1.82 – 1.70 (m, 3H), 1.71 – 1.49 (m, 9H), 1.22 
(s, 3H). 
13C NMR (101 MHz, DMSO- d6) δ 167.8, 163.7, 138.8, 130.8, 127.7, 125.8, 88.3, 40.7, 36.6, 36.1, 
28.1, 19.4. 
IR (ATR, cm-1): 3398, 2902, 2846, 1711, 1616, 1453, 1239, 1086, 893. 
HRMS (TOF-ESI, m/z): calc’d for C21H25O4 (M–Cs)–: 341.1758, found: 341.1763. 
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h. Preparation of cesium 2-(((1S,3S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-
yl)oxy)-2-oxoacetate (1k) 
  
2-(((1S,3S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-yl)oxy)-2-oxoacetic acid (SI-
18): A flame-dried 25 mL round bottom flask was charged with Et2O (5 mL) and cooled to 0 °C.  
Oxalyl chloride (165 µL, 2.05 mmol, 2.05 equiv) was added. In a separate, flame-dried 2 dram 
vial, (–)-Thujol SI-17 (158 mg, 1.02 mmol)6 was dissolved in Et2O (2 mL). The alcohol was added 
dropwise to the oxalyl chloride solution at 0 °C, and the vial containing the alcohol was rinsed 
with Et2O (1 mL), which was then also added dropwise to the reaction flask. The mixture was 
stirred for 2 h at 0 °C and 1 h at 23 °C. Oxalyl chloride (40 µL, 0.51 mmol, 0.5 equiv) was then 
added at 23 °C, and the reaction was stirred for an additional 2 h, until all alcohol had been 
consumed by TLC analysis. The mixture was concentrated under reduced pressure and dried under 
high vacuum (~90 mTorr) for 10 min. The residue was subsequently taken up in Et2O (20 mL), 
and H2O (20 mL) was added carefully, dropwise. The mixture was stirred vigorously until 
bubbling ceased (10 min), and the layers were separated. The aqueous layer was extracted with 
Et2O (3 x 10 mL), and the combined organic layers were extracted with saturated aqueous NaHCO3 
(2 x 25 mL). The combined bicarbonate layers were washed with Et2O (1 x 20 mL), and were 
subsequently acidified with 1 M HCl (35 mL), which was slowly added in portions of 5 mL to 
give a pH of 3. The resulting acidified aqueous layer was extracted with Et2O (4 x 20 mL), and the 
combined organic layers washed with a saturated aqueous solution of NaCl (1 x 40 mL), dried 
with Na2SO4, filtered, and concentrated under reduced pressure to afford SI-18 as a clear oil (216 
mg, 93% yield). Note: this oil will slowly decompose, even under high vacuum, if left for extended 
periods of time (> 6 h). This decomposition was noted with slight color change to purple. The oil 
should be dried and carried forward as quickly as possible.  
[α]D25 = –38.2° (c = 0.18, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 6.78 (s, 1H), 4.87 (dt, J = 9.0, 7.3 Hz, 1H), 2.49 (p, J = 7.0 Hz, 
1H), 2.10 (dd, J = 12.4, 7.6 Hz, 1H), 1.96 – 1.85 (m, 1H), 1.30 (dt, J = 13.7, 6.8 Hz, 1H), 0.98 (d, 
oxalyl chloride
Et2O, 0 to 23 °C
then H2OSI-17 SI-18
93% yield
OH
MeiPr
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J = 6.7 Hz, 3H), 1.00 – 0.88 (m, 1H), 0.94 (d, J = 5.1 Hz, 3H), 0.92 (d, J = 5.0 Hz, 3H), 0.42 – 
0.30 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ 157.8, 157.7, 79.8, 35.9, 33.1, 31.1, 30.0, 27.9, 20.2, 19.7, 15.3, 
14.6. 
FTIR (NaCl, thin film, cm-1): 3178, 2960, 2874, 1744, 1203, 979. 
HRMS (TOF-ESI, m/z): calc’d for C12H17O4 (M–H)–: 225.1127, found: 225.1122. 
 
  
cesium 2-(((1S,3S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-yl)oxy)-2-oxoacetate 
(1k): A 20 mL scintillation vial was charged with oxalic acid SI-18 (211 mg, 0.93 mmol) and THF 
(3.1 mL). Cs2CO3 (152 mg, 0.47 mmol, 0.5 equiv) was taken up in H2O (1.05 mL) in a separate 
vial, and transferred to the vigorously stirred acid at room temperature. The vial containing the 
base was rinsed with H2O (0.5 mL) and transferred dropwise to the reaction. After stirring 
vigorously at room temperature for 5 min, the mixture was concentrated under reduced pressure 
and azeotroped with PhMe (6 x 5 mL) to afford 1k as a white solid (333 mg, quant. yield).  
1H NMR (400 MHz, DMSO-d6) δ 4.54 (dt, J = 9.3, 7.3 Hz, 1H), 2.26 (p, J = 6.9 Hz, 1H), 1.86 
(dd, J = 12.2, 7.7 Hz, 1H), 1.65 (ddd, J = 12.2, 9.4, 1.4 Hz, 1H), 1.27 (hept, J = 6.7 Hz, 1H), 0.93 
(d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.9 Hz, 3H), 0.91 – 0.82 (m, 1H), 0.78 (d, J = 7.0 Hz, 3H), 0.39 
(dd, J = 5.1, 3.9 Hz, 1H), 0.25 (ddd, J = 8.3, 5.1, 1.4 Hz, 1H). 
13C NMR (101 MHz, DMSO-d6) δ 167.2, 162.8, 72.6, 35.1, 32.4, 30.3, 29.6, 27.5, 20.1, 19.5, 15.1, 
13.8. 
IR (ATR, cm-1): 3408, 2957, 1718, 1633, 1375, 1202, 1037. 
HRMS (TOF-ESI, m/z): calc’d for C12H17O4 (M–Cs)–: 225.1127, found: 225.1135. 
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i. Preparation of cesium 2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoacetate 
(1m) 
  
2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoacetic acid (SI-19): A flame-dried 
100 mL round bottom flask was charged with (–)-menthol (400 mg, 2.56 mmol) and Et2O (20 mL). 
The flask was cooled to 0 °C, and oxalyl chloride (0.41 mL, 5.12 mmol, 2.0 equiv) was added 
dropwise. The mixture was warmed to room temperature after 10 min, and after an additional 1.5 
h, TLC analysis indicated consumption of (–)-menthol. The reaction was carefully quenched at 0 
°C by the dropwise addition of H2O (30 mL) after addition of a vent needle. The mixture was 
stirred vigorously and warmed to room temperature. The layers were separated, and the aqueous 
layer extracted with Et2O (3 x 15 mL), and the combined organic layers dried with MgSO4, filtered, 
and concentrated under reduced pressure and azeotroped with pentane (4 x 20 mL) to afford SI-
19 as a clear oil (584 mg, quant. yield).  
[α]D25 = –80.8° (c = 0.89, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 6.08 (bs, 1H), 4.87 (td, J = 11.0, 4.5 Hz, 1H), 2.05 (dddd, J = 11.9, 
4.4, 3.4, 1.9 Hz, 1H), 1.88 (heptd, J = 6.9, 2.7 Hz, 1H), 1.78 – 1.67 (m, 2H), 1.63 – 1.45 (m, 2H), 
1.18 (td, J = 12.0, 11.0 Hz, 1H), 1.13 – 1.01 (m, 1H), 0.94 (d, J = 6.5 Hz, 3H), 0.99 – 0.84 (m, 
1H), 0.91 (d, J = 7.0 Hz, 3H), 0.77 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 158.0, 157.5, 79.7, 46.7, 40.3, 34.0, 31.6, 26.3, 23.4, 22.0, 20.7, 
16.3. 
FTIR (NaCl, thin film, cm-1): 3180, 2957, 2872, 1739, 1456, 1202, 950. 
HRMS (TOF-ESI, m/z): calc’d for C12H19O4 (M-H)–: 227.1289, found: 227.1283. 
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cesium 2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoacetate (1m): Oxalic acid 
SI-19 (566 mg, 2.48 mmol) was taken up in THF (8.3 mL). Cs2CO3 (404 mg, 1.24 mmol, 0.5 
equiv) was taken up in H2O (3.1 mL) in a vial, and transferred dropwise to the vigorously stirred 
acid at room temperature. The vial containing the base was rinsed with H2O (1 mL) and transferred 
dropwise to the reaction. After stirring vigorously at room temperature for 10 min, the mixture was 
concentrated under reduced pressure and azeotroped with PhMe (6 x 20 mL) to afford 1m as a 
white solid (889 mg, quant. yield). This resulting cesium oxalate is moderately hygroscopic, and 
was generally stored and weighed out in a nitrogen-filled glovebox. 
1H NMR (400 MHz, D2O) δ 4.75 (td, J = 11.0, 4.5 Hz, 1H), 1.94 (dtd, J = 13.0, 3.9, 1.9 Hz, 1H), 
1.80 (heptd, J = 7.0, 2.6 Hz, 1H), 1.68 (ddt, J = 12.6, 9.1, 3.0 Hz, 2H), 1.55 – 1.40 (m, 2H), 1.17 
– 1.01 (m, 2H), 0.89 (d, J = 6.5 Hz, 3H), 0.96 – 0.81 (m, 1H), 0.87 (d, J = 7.1 Hz, 3zH), 0.73 (d, J 
= 7.1 Hz, 3H). 
13C NMR (101 MHz, D2O) δ 167.3, 167.2, 80.0, 49.1, 42.6, 36.3, 33.7, 28.6, 25.8, 24.0, 22.5, 18.4. 
IR (ATR, cm-1): 2954, 1708, 1645, 1370, 1196, 963. 
HRMS (TOF-ESI, m/z): calc’d for C12H19O4 (M–Cs)–: 227.1289, found: 227.1280. 
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j. Preparation of cesium 2-oxo-2-(((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-
yl)oxy)acetate (1n) 
 
methyl ((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl) oxalate (SI-20): To a 100 mL 
round bottom flask containing a solution of (+)-fenchol (400 mg, 2.59 mmol) in CH2Cl2 (24 mL) 
at 0 °C was added Et3N (0.54 mL, 3.89 mmol, 1.5 equiv), DMAP (32 mg, 0.26 mmol, 0.1 equiv), 
and methyl oxalyl chloride (0.29 mL, 3.11 mmol, 1.2 equiv) dropwise via syringe. The reaction 
was stirred at room temperature for 3 h followed by the addition of a 3:1 mixture of a saturated 
aqueous solution of NH4Cl and a saturated aqueous solution of NaCl (8 mL). The organic layer 
was collected and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL ). The combined 
organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude residue was purified by silica gel chromatography (5–10% Et2O/hexanes) to furnish methyl 
oxalate SI-20 (617 mg, 99% yield) as a transparent crystalline solid.  
TLC Rf = 0.63 (20% EtOAc/hexanes, UV, KMnO4). 
[α]D25 = +48.8° (c = 1.00, CHCl3).  
1H NMR (400 MHz, CDCl3) δ 4.50 (d, J = 2.0 Hz, 1H), 3.89 (s, 3H), 1.89 – 1.66 (m, 4H), 1.66 – 
1.56 (m, 1H), 1.47 (tdd, J = 12.6, 5.7, 4.0 Hz, 1H), 1.23 (dd, J = 10.4, 1.6 Hz, 1H), 1.19 – 1.08 
(m, 1H), 1.12 (s, 3H), 1.07 (s, 3H), 0.81 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 158.7, 158.4, 89.6, 53.5, 48.6, 48.4, 41.5, 39.9, 29.8, 26.6, 25.9, 
20.2, 19.4. 
FTIR (NaCl, thin film, cm-1): 2960, 2877, 1770, 1747, 1462, 1369, 1322, 1202, 1170, 1030, 968. 
HRMS (TOF-ESI, m/z): calc’d for C13H20O4Na (M+Na)+: 263.1254, found: 263.1259. 
 
  
cesium 2-oxo-2-(((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)oxy)acetate (1n): A 20 
mL scintillation vial was charged with methyl oxalate SI-20 (755 mg, 3.14 mmol), THF (9.8 mL), 
and H2O (0.17 mL). A 1 M aqueous solution of CsOH (3.14 mL, 3.14 mmol, 1.0 equiv) was added 
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dropwise to the solution with vigorous stirring. After the addition was complete, the mixture was 
stirred for an additional 5 min. The reaction was concentrated under rotary evaporation to remove 
the THF. The aqueous layer was washed with Et2O (3 x 2.5 mL) and then concentrated under 
reduced pressure using rotary evaporation followed by high vacuum (~50 mTorr) to afford cesium 
oxalate 1n as a white solid (1.078 g, 96% yield). 
[α]D25 = +25.1° (c = 0.98, MeOH). 
1H NMR (400 MHz, DMSO-d6) δ 4.17 (d, J = 1.9 Hz, 1H), 1.76 – 1.51 (m, 4H), 1.40 (tdd, J = 
12.3, 5.6, 4.0 Hz, 1H), 1.14 (dd, J = 10.0, 1.6 Hz, 1H), 1.06 – 1.01 (m, 1H), 1.03 (s, 3H), 0.99 (s, 
3H), 0.71 (s, 3H). 
13C NMR (101 MHz, DMSO-d6) δ 168.2, 163.1, 83.6, 47.80, 47.78, 40.9, 29.5, 26.2, 25.5, 20.1, 
19.4. 
IR (ATR, cm-1): 3413, 2940, 2874, 1710, 1640, 1364, 1203, 1032, 1003.  
HRMS (TOF-ESI, m/z): calc’d for C12H17O4 (M–Cs)–: 225.1132, found: 225.1128. 
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k. Preparation of cesium 2-oxo-2-(((1S,4R,6S)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-
yl)oxy)acetate (1o) 
   
2-oxo-2-(((1S,4R,6S)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl)oxy)acetic acid (SI-22): A 
flame-dried 100 mL round bottom flask was charged with eucalyptol derivative SI-21 (400 mg, 
2.35 mmol)7 and Et2O (18 mL). The flask was cooled to 0 ºC, and oxalyl chloride (0.38 mL, 4.70 
mmol, 2.0 equiv) was added dropwise. The clear mixture was stirred for 1.5 h, and then warmed 
to room temperature. After stirring for 24 h, the solution was cooled to 0 °C, and oxalyl chloride 
(0.1 mL, 1.18 mmol, 0.5 equiv) was added. The mixture was warmed to room temperature and 
stirred for an additional 4 h, until all alcohol had been consumed by TLC analysis. The mixture 
was concentrated under reduced pressure and dried under high vacuum (~90 mTorr) for 5 min. 
The residue was subsequently taken up in Et2O (30 mL) and H2O (30 mL) was added carefully, 
dropwise. The mixture was stirred vigorously until bubbling ceased (10 min), and the layers were 
separated. The aqueous layer was extracted with Et2O (3 x 15 mL), and the combined organic 
layers were extracted with saturated aqueous NaHCO3 (3 x 30 mL). The combined bicarbonate 
layers were acidified with 1 M HCl (110 mL), which was slowly added in portions of 10 mL to 
give a pH of 1. The resulting acidified aqueous layer was extracted with Et2O (3 x 80 mL), and the 
combined organic layers washed with a saturated aqueous solution of NaCl (1 x 60 mL), dried 
with Na2SO4, filtered, and concentrated under reduced pressure to afford SI-22 as a white solid 
(522 mg, 92% yield) after azeotroping with pentane.  
[α]D25 = –9.5° (c = 0.53, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 9.01 (s, 1H), 4.88 (ddd, J = 9.8, 3.7, 2.0 Hz, 1H), 2.69 (ddt, J = 
14.7, 9.7, 3.3 Hz, 1H), 2.09 – 2.01 (m, 1H), 1.97 (ddd, J = 14.7, 11.6, 2.9 Hz, 1H), 1.74 – 1.64 (m, 
1H), 1.64 – 1.53 (m, 2H), 1.43 (ddd, J = 14.6, 3.6, 2.4 Hz, 1H), 1.33 (s, 3H), 1.26 (s, 3H), 1.12 (s, 
3H). 
13C NMR (101 MHz, CDCl3) δ 158.3, 158.0, 76.3, 75.1, 71.6, 33.9, 32.1, 28.7, 28.4, 25.7, 23.9, 
21.8. 
FTIR (NaCl, thin film, cm-1): 3078, 2975, 1745, 1184, 1004. 
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HRMS (TOF-ESI, m/z): calc’d for C12H17O5 (M–H)–: 241.1081, found: 241.1083. 
 
   
cesium 2-oxo-2-(((1S,4R,6S)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl)oxy)acetate (1o): 
A 20 mL scintillation vial was charged with oxalic acid SI-22 (507 mg, 2.09 mmol) and THF (7 
mL). Cs2CO3 (340.7 g, 1.05 mmol, 0.5 equiv) was taken up in H2O (2.5 mL) in a separate vial, and 
transferred to the vigorously stirred acid at room temperature. The vial containing the base was 
rinsed with H2O (1 mL) and transferred dropwise to the reaction. After stirring vigorously at room 
temperature for 5 min, the mixture was concentrated under reduced pressure and azeotroped with 
PhMe (8 x 6 mL) to afford 1o as a white solid (780 mg, quant. yield). This resulting cesium oxalate 
is moderately hygroscopic, and was generally stored and weighed out in a nitrogen-filled glovebox. 
1H NMR (400 MHz, D2O) δ 4.75 (ddd, J = 9.7, 3.6, 1.4 Hz, 1H), 2.63 (ddt, J = 13.1, 9.8, 3.2 Hz, 
1H), 2.08 – 1.87 (m, 2H), 1.70 – 1.52 (m, 3H), 1.44 (dt, J = 14.7, 3.2 Hz, 1H), 1.30 (s, 3H), 1.23 
(s, 3H), 1.05 (s, 3H). 
13C NMR (101 MHz, D2O) δ 167.1, 167.0, 78.5, 77.1, 74.7, 35.9, 33.9, 30.6, 30.2, 27.9, 25.8, 23.5. 
IR (ATR, cm-1): 2969, 1714, 1634, 1377, 1196, 1005, 874. 
HRMS (TOF-ESI, m/z): calc’d for C12H17O5 (M–Cs)–: 241.1081, found: 241.1090. 
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3. Deoxychlorination Reactions 
Optimization of Reaction Parameters 
 
   
Entrya Deviation from  
standard conditions 
NMR yield 
2a (%)b 
1 None 82 
2 ETCA (not distilled) 32 
3 HCA instead of ETCA 17 
4 A instead of ETCA 0 
5 B instead of ETCA 5 
6 C instead of ETCA 75 
7 NCS instead of ETCA 32 
8 CCl4 (10 equiv) instead of ETCA 42 
9 MeCN instead of CH2Cl2 20 
10 1,4-dioxane instead of CH2Cl2 36 
11 
12 
THF instead of CH2Cl2 
1,2-dichloroethane instead of CH2Cl2 
34 
0 
13 With H2O (10 equiv) 72 
14 
15 
16 
17c 
In dark 
No [Ir] catalyst 
No ETCA 
36 ºC 
0 
0 
0 
82 
aPerformed on 37 mg (0.1 mmol) scale ETCA = ethyl trichloroacetate, HCA = hexachloroacetone, A = ethyl 
chloroacetate, B = diethyl 2-chloromalonate, C = dimethyl 2,2-dichloromalonate. Internal temperature measured 
using a thermocouple as 27 °C. 
bYields determined by quantitative 1H NMR spectrometry using pyrazine as a standard.  
cReaction directly irradiated with a Kessil A160WE blue LED lamp ~ 4 cm away. Internal temperature measured 
using a thermocouple. 
 
General Procedure #1 (reaction optimization): On a benchtop, 1 dram vials each containing a 
stir bar were successively charged with cesium oxalate 1a (37 mg, 0.10 mmol), 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1.1 mg, 0.001 mmol, 0.01 equiv), degassed solvent (0.5 mL) that 
was sparged with a balloon of argon for 15 min, and chlorinating agent (0.15 mmol, 1.5 equiv). 
The vials were sparged with argon for an additional 10–15 seconds and then sealed under a stream 
of argon with a screw cap. The vials were subsequently irradiated with blue LED light for 4 h in a 
Hepatochem device. Following this time, each of the vials was removed from the Hepatochem 
OPh
Me Me O
OCs
O
1a 2a
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 ºC, 4 h, blue LED
ClPh
Me Me
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device. A 1:1 mixture of a saturated aqueous solution of NaCl and H2O (1.5 mL) was added to 
each vial and then each reaction was extracted with Et2O (3 x 3 mL). Each of the combined organic 
extracts was dried over MgSO4, filtered, and concentrated under rotary evaporation in a rotavap 
water bath at 27 °C (at a pressure of ~60–100 mmHg for volatile products). NMR yields were 
determined using quantitative 1H NMR spectroscopy with pyrazine as an added standard. The 1H 
NMR data for tertiary chloride 2a was consistent with those reported in the literature.8 
 
General Procedure #2 (substrate scope): On a benchtop, a 20 mL scintillation vial containing a 
stir bar was successively charged with cesium oxalate (1 equiv), Ir[dF(CF3)ppy]2(dtbbpy)PF6 (0.01 
equiv), degassed CH2Cl2 (1.5 mL, sparged with a balloon of argon for 15 min), and ETCA (1.5 
equiv). The vial was sparged with argon for an additional 10–15 seconds and then sealed under a 
stream of argon with a screw cap. The vial was placed in a Hepatochem device and irradiated with 
blue LED light. Tertiary alcohol-derived cesium oxalates were irradiated for 4 h and secondary 
alcohol-derived cesium oxalates were irradiated for 24 h. The vial was subsequently removed from 
the Hepatochem device and transferred to a separatory funnel with a 1:1 mixture of a saturated 
aqueous solution of NaCl and H2O (1.5 mL). The mixture was extracted with Et2O (3 x 3 mL) and 
the combined organic extracts were dried over MgSO4, filtered, and concentrated under rotary 
evaporation in a rotavap water bath at 27 °C (at a pressure of ~60–100 mmHg for volatile 
products). The crude residue was purified by silica gel chromatography to afford the chlorinated 
products. To mitigate elimination of tertiary chlorides to the corresponding alkenes during 
purification, silica gel columns were treated with Et3N as needed for selected products (see below).  
Chlorides 2a, 2b, 2c, 2d, 2f, 2i, and 2o were contaminated with ETCA following purification 
by column chromatography. For these products, the remaining ETCA was removed by dissolving 
in THF (0.9 mL) and MeOH (0.45 mL), cooling to 0 ºC, and then adding a 3 M aqueous solution 
of NaOH (0.3 mL) dropwise. After stirring at 0 ºC for 5 min and room temperature for 25 min, the 
solution was diluted with H2O (1 mL) and extracted with Et2O (4 x 2 mL). The combined organic 
extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to afford the 
chloride products. 
 
 
(3-chloro-3-methylbutyl)benzene (2a): Prepared according to general procedure #2 using cesium 
oxalate 1a (115 mg, 0.31 mmol).2 Purification of the orange-colored crude residue by silica gel 
OPh
Me Me O
OCs
O
1a 2a
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 ºC, 4 h, blue LED
84% yield
ClPh
Me Me
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column chromatography (0–2% Et2O/pentane). Residual ETCA was removed by treatment with 
aqueous NaOH according to general procedure #2 to provide chloride 2a as a pale yellow oil (48 
mg, 84% yield). The 1H NMR data for tertiary chloride 2a was consistent with those reported in 
the literature.8  
TLC Rf = 0.34 (hexanes, p-anisaldehyde) 
 
 
2-(2-(1-chlorocyclopentyl)ethyl)-1,3-dioxane (2b): Prepared according to general procedure #2 
using cesium oxalate 1b (119 mg, 0.29 mmol). A silica gel column was eluted with two column 
volumes of 3% Et3N/5% Et2O/pentane. Purification of the crude residue was then performed on 
this column (5–15% Et2O/pentane). Residual ETCA was removed by treatment with aqueous 
NaOH according to general procedure #2 to furnish a 94:6 mixture of chloride 2b and alkene SI-
23 as pale yellow oil (61 mg, 92% yield: 87% 2b, 5% SI-23). 1H NMR analysis indicated that 
alkene SI-23  did not form until after the NaOH hydrolysis procedure. 
TLC Rf (2b)= 0.37 (15% Et2O/pentane, p-anisaldehyde). 
TLC Rf (SI-23)= 0.43 (15% Et2O/pentane, p-anisaldehyde). 
1H NMR (2b, 400 MHz, CDCl3) δ 4.55 (t, J = 4.6 Hz, 1H), 4.09 (ddt, J = 10.5, 5.0, 1.4 Hz, 2H), 
3.83 – 3.67 (m, 2H), 2.15 – 1.99 (m, 3H), 1.99 – 1.82 (m, 6H), 1.78 – 1.62 (m, 4H), 1.33 (dtt, J = 
13.5, 2.6, 1.4 Hz, 1H). 
13C NMR (2b, 101 MHz, CDCl3) δ 102.1, 82.7, 67.0, 42.4, 37.5, 31.9, 25.9, 23.2. 
FTIR (NaCl, thin film, cm-1): 2964, 2850, 2730, 2657, 1449, 1406, 1378, 1241, 1146, 1080, 998. 
HRMS (FAB+, m/z): calc’d for C11H18ClO2 (M+H–H2)+: 217.0995, found: 217.0983. 
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2-(2-((1r,4r)-4-(tert-butyl)-1-chlorocyclohexyl)ethyl)-1,3-dioxane (2c): Prepared according to 
general procedure #2 using cesium oxalate 1c (140 mg, 0.30 mmol). A silica gel column was eluted 
with two column volumes of 3% Et3N/2% Et2O/pentane. Purification of the crude residue was then 
performed on this column (5–10% pentane/Et2O). Residual ETCA was removed by treatment with 
aqueous NaOH according to general procedure #2 to give chloride 2c as a 9.8:1 mixture of 
inseparable diastereomers as a clear colorless oil (72 mg, 85% yield).  
TLC Rf = 0.23 (10% Et2O/hexanes, KMnO4). 
1H NMR (major diastereomer, 400 MHz, CDCl3) δ 4.55 (t, J = 4.5 Hz, 1H), 4.10 (ddt, J = 10.4, 
5.0, 1.4 Hz,2H), 3.76 (dddd, J = 12.7, 10.5, 2.6, 1.5 Hz, 2H), 2.20 – 2.03 (m, 1H), 2.05 – 1.96 (m, 
2H), 1.93 – 1.75 (m, 4H), 1.70 – 1.57 (m, 2H), 1.57 – 1.30 (m, 5H), 0.93 (tt, J = 11.8, 3.5 Hz, 1H), 
0.86 (s, 9H). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 102.4, 75.5, 67.1, 47.7, 40.2, 40.1, 32.6, 30.0, 
27.7, 25.9, 23.0. 
FTIR (NaCl, thin film, cm-1): 2947, 2849, 2730, 2658, 1448, 1404, 1366, 1287, 1240, 1147, 1079, 
1042, 1009, 975. 
HRMS (FAB+, m/z): calc’d for C16H28ClO2 (M+H–H2)+: 287.1778, found: 287.1755. 
 
  
2-(2-((1r,4r)-4-(tert-butyl)-1-chlorocyclohexyl)ethyl)-1,3-dioxane (2c): Prepared according to 
general procedure #2 using the epimer of cesium oxalate 1c, cesium oxalate 1c’ (114 mg, 0.24 
mmol). Purification of the crude residue was then performed as above to provide chloride 2c as a 
9.4:1 mixture of inseparable diastereomers as a clear colorless oil (58 mg, 83% yield).  
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2-(2-((1r,4r)-4-(tert-butyl)-1-chlorocyclohexyl)ethyl)-1,3-dioxane (2c): Prepared according to 
the general procedure #2 using a 2.5:1 mixture of cesium oxalates 1c and 1c’ respectively (139 
mg, 0.29 mmol). Purification of the crude residue was then performed as above to give chloride 
2c as a 9.3:1 mixture of inseparable diastereomers as a clear colorless oil (70 mg, 83% yield).  
 
  
2-(2-((1R,4aR,8aS)-1-chlorodecahydronaphthalen-1-yl)ethyl)-1,3-dioxane (2d): Prepared 
according to general procedure #2 using cesium oxalate 1d (147 mg, 0.31 mmol). A silica gel 
column was eluted with two column volumes of 3% Et3N/5% Et2O/pentane. Purification of the 
crude residue was then performed on this column (5–15% pentane/Et2O). Residual ETCA was 
removed by treatment with aqueous NaOH according to general procedure #2 to deliver chloride 
2d as a 2.9:1 mixture of inseparable diastereomers as a clear colorless oil (77 mg, 86% yield).  
TLC Rf = 0.29 (15% Et2O/pentane, p-anisaldehyde). 
1H NMR (2.4:1 dr, asterisk denotes minor diastereomer, 400 MHz, CDCl3) δ *4.55 – 4.53 (m, 
0.3H), 4.51 (dd, J = 5.5, 4.1 Hz, 1H), 4.10 (ddq, J = 10.2, 5.0, 1.8, 1.4 Hz, 2.7H), 3.85 – 3.67 (m, 
2.7H), *2.30 – 2.20 (m, 0.5H), 2.16 – 1.96 (m, 2.8H), 1.98 – 1.87 (m, 1.6H), 1.87 – 1.70 (m, 6.4H), 
1.70 – 1.40 (m, 9.6H), 1.40 – 1.08 (m, 7.7H), 1.08 – 0.77 (m, 4.3H). 
13C NMR (asterisk denotes minor diastereomer, 101 MHz, CDCl3) δ *102.5, 102.4, *79.8, 79.0, 
67.1, *55.8, 51.1, *40.5, *39.8, 38.9, 37.0, *35.0, 34.6, 34.0, *33.9, 30.2, *29.9, *28.1, *26.9, 
*26.7, 26.6, 26.3, 26.1, *25.93, 25.91, *23.3, 21.9.  
FTIR (NaCl, thin film, cm-1): 2928, 2850, 2730, 2662, 1449, 1404, 1377, 1286, 1244, 1144, 1076, 
1001. 
HRMS (FAB+, m/z): calc’d for C16H26ClO2 (M+H–H2)+: 285.1621, found: 285.1650. 
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2-((1R,2R,4aS,8aS)-2-chloro-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)ethyl pivalate 
(2e): Prepared according to general procedure #2 using cesium oxalate 1e (165 mg, 0.30 mmol). 
A silica gel column was eluted with two column volumes of 3% Et3N/2% Et2O/pentane. 
Purification of the crude residue was then performed on this column (isocratic: 2% Et2O/hexanes) 
to afford a 92:2:6 mixture of chloride 2e, alkene SI-24, and alkene SI-25 as a viscous yellow oil 
(96 mg, 90% yield: 83% 2e 5.9:1 dr, 2% SI-24, 5% SI-25).  
TLC Rf (2e) = 0.28 (3% Et2O/pentane, p-anisaldehyde). 
[α]D25 = +3.6° (c = 1.01, CHCl3). 
1H NMR (2e, asterisk denotes minor diastereomer, 400 MHz, CDCl3) δ 4.17 (td, J = 10.3, 6.0 Hz, 
1H), 4.07 (td, J = 10.2, 6.1 Hz, 1H), *4.05 – 3.98 (m, 0.34 H), (dt, J = 12.9, 3.3 Hz, 1H), 2.12 – 
1.98 (m, 1H), 1.92 – 1.75 (m, 1H), 1.74 – 1.61 (m, 3H), 1.59 – 1.51 (m, 4H), 1.52 – 1.24 (m, 3H), 
1.19 (d, J = 1.6 Hz, 11H), 1.16 – 1.07 (m, 1H), 1.05 – 0.90 (m, 3H), 0.86 (d, J = 1.7 Hz, 4H), 0.85 
– 0.79 (m, 3H), 0.77 (s, 3H). 
13C NMR (2e, asterisk denotes minor diastereomer, 101 MHz, CDCl3) δ *178.83, 178.80, 78.0, 
*75.7, 66.4, *66.0, 58.9, *57.2, *56.1, 56.0, 46.5, *45.2, *42.0, 41.8, 40.7, 39.9, *39.6, *39.4, 
38.83*, 38.82, *34.3, *33.5, 33.4, 33.3, 27.4, *26.9, *26.4, 26.2, *21.8, 21.6, 21.1, *18.8, 18.4, 
*18.2, 15.7, *15.5. 
FTIR (NaCl, thin film, cm-1): 2953, 1728, 1480, 1460, 1390, 1366, 1284, 1230, 1157, 1056, 1035, 
979. 
HRMS (EI, m/z): calc’d for C21H37O2Cl (M+×)+: 356.2480, found: 356.2482. 
 
  
7-benzyl-7-chloro-6,7,8,9-tetrahydro-5H-benzo[7]annulene (2f): Prepared according to general 
procedure #2 using cesium oxalate 1f (139 mg, 0.31 mmol). A silica gel column was eluted with 
two column volumes of 2% Et3N/hexanes. Purification of the crude material was then performed 
on this column (isocratic: 2% Et2O/hexanes). Residual ETCA was removed by treatment with 
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aqueous NaOH according to general procedure #2 to give chloride 2f as a white crystalline solid 
(55 mg, 67% yield). 
TLC Rf = 0.35 (3% Et2O/pentane, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.17 (m, 5H), 7.09 (d, J = 1.1 Hz, 4H), 3.32 (t, J = 13.4 Hz, 
2H), 3.09 (s, 2H), 2.58 (dd, J = 14.9, 7.0 Hz, 2H), 2.27 – 2.06 (m, 2H), 1.72 (t, J = 13.3 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ 142.4, 136.1, 131.4, 129.0, 128.0, 127.0, 126.4, 78.9, 53.0, 41.0, 
31.0. 
FTIR (NaCl, thin film, cm-1): 3062, 3028, 2935, 2856, 1948, 1881, 1806, 1604, 1494, 1453, 1208, 
1187, 1080, 1037. 
HRMS (EI, m/z): calc’d for C18H19Cl (M+×)+: 270.1175, found: 270.1169. 
 
  
2-(2-(7-chloro-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-yl)ethyl)-1,3-dioxane (2g): Prepared 
according to general procedure #2 using cesium oxalate 1g (149 mg, 0.31 mmol). A silica gel 
column was eluted with two column volumes of 2% Et3N/5% Et2O/hexanes. Purification of the 
crude material was then performed on this column (3–5% EtOAc/hexanes) to afford chloride 2g 
as a viscous yellow oil (76 mg, 84% yield). 
TLC Rf = 0.21 (5% EtOAc/hexanes, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 7.12 (s, 4H), 4.65 – 4.48 (m, 1H), 4.10 (ddt, J = 10.4, 5.0, 1.4 Hz, 
2H), 3.86 – 3.61 (m, 2H), 3.15 – 3.45 (br d, J = 14.4 Hz, 2H), 2.75 – 2.47 (m, 2H), 2.27 – 2.15 (m, 
2H), 2.07 (dtt, J = 13.5, 12.5, 5.0 Hz, 1H), 1.97 – 1.80 (m, 4H), 1.66 (d, J = 14.0 Hz, 2H), 1.40 – 
1.29 (m, 1H). 
13C NMR (101 MHz, CDCl3) δ 142.4, 128.9, 126.4, 102.2, 79.1, 67.0, 41.1, 31.0, 30.1, 25.9. 
FTIR (NaCl, thin film, cm-1): 2938, 2852, 1764, 1493, 1453, 1404, 1377, 1239, 1145, 1086, 1004. 
HRMS (EI, m/z): calc’d for C17H22O2Cl (M+H–H2)+: 293.1308, found: 293.1322. 
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procedure #2 using cesium oxalate 1h (146 mg, 0.31 mmol). A silica gel column was eluted with 
two column volumes of 2% Et3N/pentane. Purification of the crude residue was then performed 
on this column (isocratic: 2% Et2O/pentane) to afford an inseparable 85:8:7 mixture of chloride 
2h, alkene SI-26, and alkene SI-27 as a white crystalline solid (49 mg, 54% yield: 46% 2h, 4% 
SI-26, 4% SI-27). 
TLC Rf = 0.43 (2% EtOAc/hexanes, KMnO4). 
1H NMR (2h, 400 MHz, CDCl3) δ 7.33 – 7.19 (m, 5H), 3.19 (d, J = 13.7 Hz, 1H), 2.91 (d, J = 
13.7 Hz, 1H), 2.13 – 1.96 (m, 3H), 1.88 (d, J = 3.0 Hz, 6H), 1.82 – 1.58 (m, 9H), 1.29 (d, J = 0.8 
Hz, 3H). 
13C NMR (2h, 101 MHz, CDCl3) δ 137.8, 131.8, 127.7, 126.6, 82.6, 43.0, 41.2, 37.1, 37.0, 28.9, 
23.1. 
FTIR (NaCl, thin film, cm-1): 2905, 2849, 1763, 1604, 1496, 1451, 1082, 972. 
HRMS (TOF-ES+, m/z): calc’d for C19H25ClH (M+H)+: 289.1718, found: 289.1723. 
 
  
(2S,5S)-5-(2-chloropropan-2-yl)-2-methyl-2-vinyltetrahydrofuran (2i): Prepared according to 
general procedure #2 using cesium oxalate 1i (126 mg, 0.34 mmol). The crude residue was purified 
by silica gel chromatography (3–5% Et2O/pentane). Residual ETCA was removed by treatment 
with aqueous NaOH according to general procedure #2 to provide chloride 2i as a white crystalline 
solid (33.4 mg, 53% yield). 
TLC Rf = 0.37 (3% Et2O/pentane, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 5.85 (dd, J = 17.3, 10.6 Hz, 1H), 5.18 (dd, J = 17.3, 1.6 Hz, 1H), 
5.00 (dd, J = 10.6, 1.6 Hz, 1H), 3.98 (dd, J = 7.4, 6.1 Hz, 1H), 2.03 – 1.93 (m, 2H), 1.88 (ddd, J = 
12.0, 8.0, 4.9 Hz, 1H), 1.81 – 1.68 (m, 1H), 1.55 (d, J = 1.5 Hz, 6H), 1.34 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 143.5, 111.6, 85.8, 84.1, 71.5, 37.1, 29.9, 27.8, 27.7, 26.7. 
FTIR (NaCl, thin film, cm-1): 3088, 2979, 2871, 1750, 1643, 1461, 1386, 1369, 1302, 1242, 1119, 
1063, 1028, 921. 
HRMS (GC-EI, m/z): calc’d for C10H17OCl (M+H–H2)+: 188.0943, found: 188.0968. 
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(4-chloro-4-methylpiperidin-1-yl)(phenyl)methanone (2j): Prepared according to general 
procedure #2 using cesium oxalate 1j (146 mg, 0.31 mmol). The crude residue was purified by 
silica gel chromatography (10–40% EtOAc/hexanes), furnishing 2j as a light yellow solid (41 mg, 
55% yield). 
TLC Rf = 0.28 (33% EtOAc/hexanes, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) δ 7.44 – 7.34 (m, 5H), 4.49 – 4.68 (br d, J = 13.4 Hz, 1H), 3.55 – 
3.73 (br s, 1H), 3.55 – 3.37 (m, 1H), 3.34 – 3.11 (br s, 1H), 2.11 – 1.90 (m, 1H), 1.92 – 1.73 (m, 
2H), 1.73 – 1.55 (m, 1H), 1.66 (s, 3H).  
13C NMR (101 MHz, CDCl3) δ 170.5, 136.0, 129.8, 128.6, 127.0, 69.3, 44.5, 41.2, 40.3, 38.8, 
33.4. 
FTIR (NaCl, thin film, cm-1): 3059, 2946, 2873, 1634, 1578, 1433, 1372, 1288, 1254, 1168, 1130, 
1107, 967. 
HRMS (TOF-ESI, m/z): calc’d for C13H16ClNOH+ (M+H)+: 238.0993, found: 238.0986. 
 
  
(1S,3R,4R,5R)-3-chloro-1-isopropyl-4-methylbicyclo[3.1.0]hexane (2k): Prepared according to 
general procedure #2 using cesium oxalate 1k (114 mg, 0.32 mmol). The crude residue was 
purified by silica gel chromatography (isocratic: hexanes) to afford chloride 2k as a fragrant clear 
colorless oil (27.4 mg, 50% yield, 20:1 dr). The spectral data was consistent with those reported 
in the literature.9  
TLC Rf  = 0.70 (pentane, p-anisaldehyde). 
[α]D25 = –18.5° (c = 0.96, CHCl3). 
1H NMR (19:1 dr, major diastereomer, 400 MHz, CDCl3) δ 3.95 – 3.80 (m, 1H), 2.38 (ddd, J = 
14.5, 7.9, 1.9 Hz, 1H), 2.17 (qd, J = 7.1, 3.0 Hz, 1H), 1.79 (dd, J = 14.4, 3.5 Hz, 1H), 1.28 (dt, J = 
13.4, 6.7 Hz, 1H), 1.06 (d, J = 7.2 Hz, 3H), 0.98 – 0.94 (m, 1H), 0.93 (d, J = 6.8 Hz, 3H), 0.90 (d, 
J = 6.9 Hz, 3H), 0.86 (ddt, J = 8.4, 3.9, 1.0 Hz, 1H), 0.57 (ddd, J = 8.4, 4.8, 1.7 Hz, 1H). 
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13C NMR (19:1 dr, major diastereomer, 101 MHz, CDCl3) δ 65.7, 47.2, 38.0, 35.2, 33.1, 29.9, 
20.7, 20.3, 19.9, 19.0. 
FTIR (NaCl, thin film, cm-1): 2959, 2872, 1458, 1382, 1298, 1252, 1064, 1032, 940. 
 
  
(1R,2S,4R)-2-chloro-1-isopropyl-4-methylcyclohexane (2l): Prepared according to general 
procedure #2 using cesium oxalate 1l (110 mg, 0.31 mmol). The crude residue was purified by 
silica gel chromatography (isocratic: pentane) to furnish chloride 2l as a clear colorless oil (42.5 
mg, 80% yield, 20:1 dr). 
TLC Rf = 0.90 (pentane, p-anisaldehyde). 
[α]D25 = +31.8° (c = 0.95, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 4.26 (td, J = 7.5, 4.0 Hz, 1H), 2.02 (ddt, J = 14.2, 7.3, 5.0 Hz, 2H), 
1.91 – 1.76 (m, 2H), 1.76 – 1.65 (m, 1H), 1.60 – 1.37 (m, 2H), 1.36 – 1.19 (m, 2H), 0.93 (dd, J = 
6.9, 1.6 Hz, 6H), 0.86 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 62.0, 49.9, 41.1, 30.3, 28.0, 27.4, 21.1, 20.5, 19.9, 18.2. 
FTIR (NaCl, thin film, cm-1): 2959, 2928, 2872, 1461, 1386, 1210, 1022, 975. 
HRMS (GC-EI, m/z): calc’d for C10H19Cl (M+×)+: 174.1175, found: 174.1162. 
 
  
(1S,2S,4R)-2-chloro-1-isopropyl-4-methylcyclohexane (2m): Prepared according to general 
procedure #2 using cesium oxalate 1m (108.5 mg, 0.30 mmol). The crude residue was purified by 
silica gel chromatography (isocratic: pentane) to afford chloride 2m as a clear colorless oil (25.3 
mg, 50% yield, 1.5:1 dr). The 1H NMR spectrum of the mixture of diastereomers was consistent 
with those reported for the individual diastereomers, neomenthyl chloride10 and commercially 
available (−)-menthyl chloride. 
TLC Rf = 0.72 (pentane, p-anisaldehyde). 
FTIR (NaCl, thin film, cm-1): 2956, 2928, 2870, 1454, 1370, 1278. 
80% yield
20:1 dr1l
Me
iPr
Me
iPr
2l
ClO
O
OCs
O
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 °C, 24 h, blue LED *
1m
Me
iPr
O
O
OCs
O
Me
iPr
Cl
2m
50% yield
1.5:1 dr
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 °C, 24 h, blue LED
*
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(1S,2R,4R)-2-chloro-1,3,3-trimethylbicyclo[2.2.1]heptane (2n): Prepared according to general 
procedure#2  using cesium oxalate 1n (109 mg, 0.30 mmol). The crude residue was purified by 
silica gel chromatography (isocratic: pentane) to provide chloride 2n as a clear colorless oil (25.5 
mg, 49% yield, 6.7:1 dr). The 1H NMR spectrum of the mixture of diastereomers was consistent 
with those reported in the literature for each of the individual diastereomers.11 
TLC Rf = 0.93 (pentane, p-anisaldehyde). 
FTIR (NaCl, thin film, cm-1): 2953, 2870, 1468, 1366, 1274, 906. 
 
  
(1S,4R,6S)-6-chloro-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane (2o): Prepared according to the 
general procedure using cesium oxalate 1o (117 mg, 0.31 mmol). The crude residue was purified 
by silica gel chromatography (3–10% Et2O/pentane). Residual ETCA was removed by treatment 
with aqueous NaOH according to general procedure #2 to afford chloride 2o as a clear colorless 
fragrant oil (41.7 mg, 71% yield, 2.9:1 dr). The spectral data were consistent with those reported 
in the literature.12 
TLC Rf (major diastereomer)= 0.29 (3% Et2O/pentane, p-anisaldehyde). 
TLC Rf (minor diastereomer) = 0.24 (3% Et2O/pentane, p-anisaldeyde). 
1H NMR (major diastereomer, 400 MHz, CDCl3) δ 3.94 (ddd, J = 10.2, 4.4, 2.0 Hz, 1H), 2.74 
(ddt, J = 14.8, 10.2, 3.4 Hz, 1H), 2.15 – 2.02 (m, 1H), 2.02 – 1.86 (m, 1H), 1.81 (ddd, J = 14.8, 
4.4, 2.7 Hz, 1H), 1.69 – 1.56 (m, 2H), 1.54 (tt, J = 3.5, 2.4 Hz, 1H), 1.28 (s, 3H), 1.20 (d, J = 0.7 
Hz, 3H), 1.17 (s, 3H). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 74.2, 73.5, 59.7, 36.3, 34.6, 28.9, 28.4, 25.4, 
25.2, 21.9. 
FTIR (NaCl, thin film, cm-1): 3362, 2970, 2935, 1723, 1460, 1379, 1200, 1129, 1090, 1069, 1051, 
987. 
1n
Me
Me
Me
H
O
O
O
OCs
49% yield
6.7:1 dr
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 °C, 24 h, blue LED
Me
Me
Me
Cl
H
2n
*
2o1o
O
Me Me
Me O
O
O
OCs
O
Me Me
Me Cl
71% yield
2.9:1 dr
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 °C, 24 h, blue LED *
H H
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4. 1.3 mmol Scale Deoxychlorination Sequence. 
 
 
cesium 2-(((1S,2R,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoacetate (1l): A flame-dried 
100 mL round bottom flask attached to a 10 mL dropping funnel was charged with a solution of 
oxalyl chloride (0.11 mL, 1.29 mmol, 1.01 equiv) in THF (6.0 mL). The solution was cooled to 0 
ºC followed by dropwise addition of a solution of (+)-isomenthol (200 mg, 1.28 mmol) in THF (6 
mL) over 15 min. The transfer was made quantitative using an additional amount of THF (2 x 0.5 
mL). After the reaction was stirred at this temperature for 1 h, H2O (4.3 mL) was added and the 
resulting solution was warmed to room temperature while stirring for an additional 1 h. A saturated 
aqueous solution of NaCl (8 mL) was added, the contents were transferred to a separatory funnel, 
and the flask was rinsed with THF (2 mL) to make the transfer quantitative. The aqueous layer 
was separated and the organic layer was washed with a 2:1 mixture of a saturated aqueous solution 
of NaCl and H2O (12 mL) followed by a 1:2 mixture of saturated aqueous solution of NaCl and 
H2O (2 x 12 mL). A solution of Cs2CO3 (213 mg, 0.51 equiv) in H2O (1.0 mL) was then added. 
The contents were shaken thoroughly and then concentrated under rotary evaporation to remove 
the THF. The aqueous solution was washed with 1:1 pentane/Et2O (3 x 3 mL) and then 
concentrated using rotary evaporation followed by high vacuum (~50 mTorr) to afford cesium 
oxalate 1l (419 mg, 91% yield) as a white solid. 
 
(1S,2S,4R)-2-chloro-1-isopropyl-4-methylcyclohexane (2l): A 15 mL Schlenk tube was charged 
with cesium oxalate 1l (419 mg, 1.16 mmol), Ir[dF(CF3)ppy]2(dtbbpy)PF6 (13 mg, 0.012 mmol, 
0.01 equiv), and a magnetic stir bar. The flask was evacuated and backfilled with argon (x 3) and 
CH2Cl2 (5.8 mL) that was degassed by sparging with argon for 15 min and ETCA (0.24 mL, 1.74 
mmol, 1.5 equiv) were added. The flask was sealed and irradiated with a Kessil A160WE blue 
LED lamp placed approximately 4 cm away and cooled using a fan. The reaction was stirred 
vigorously for 24 h under these conditions (550 rpm). The blue LED was turned off and H2O (5 
mL) was added to the orange suspension. The contents were transferred to a separatory funnel and 
extracted with Et2O (4 x 10 mL). The combined organic extracts were dried over MgSO4, filtered, 
and concentrated under rotary evaporation in a rotavap water bath at 27 °C (at a pressure of ~60–
Me
iPr
OH
(+)-isomenthol
Me
iPr
O
O
O
OCs
Me
iPr
Cl
*
oxalyl chloride
THF, 0 °C
then H2O, 23 °C
91% yield
then Cs2CO3, H2O
(1.28 mmol)
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
ETCA (1.5 equiv)
CH2Cl2, 27 °C, 24 h, blue LED
71% yield
24:1 dr
(65% over 2 steps)
1l 2l
(1.16 mmol)
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100 mmHg). The crude orange material was purified by silica gel chromatography (isocratic: 
pentane) to afford chloride 2l as a clear colorless oil (144 mg, 71% yield, 24:1 dr). 
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5. Functional Group Tolerance of the Radical Deoxychlorination. 
 
  
General Procedure #3: On a benchtop, 1/2 dram vials each containing a stir bar were successively 
charged with 1l (37 mg, 0.10 mmol), Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1.2 mg, 0.001 mmol, 0.01 
equiv), additive (0.10 mmol, 1.0 equiv), CH2Cl2 (0.5 mL) that was degassed by sparging with a 
balloon of argon for 15 min, and ETCA (29 mg, 0.15 mmol, 1.5 equiv). The vials were sparged 
with argon for an additional 5 seconds, sealed under a stream of argon, and irradiated with blue 
LED light in a Hepatochem device for 12 h. After removing the vials from the Hepatochem device, 
a 1:1 mixture of saturated aqueous solution of NaCl and H2O (0.5 mL) was added to each vial. 
Each reaction was extracted with Et2O (4 x 1 mL). Each of the combined organic extracts was then 
dried over MgSO4 and filtered. A solution of a measured amount of n-dodecane standard in 
hexanes was added to each of the combined organic extracts. After thoroughly mixing the resulting 
solutions, a ~1 mL aliquot was taken for each sample and analyzed by GC-flame ionization 
detection. The yields of 2l and additive were calculated based on a calibrated response factor (RF).  
 
Response Factor (RF) = (Area standard/Area additive) x (mmol additive/mmol standard) 
RF 2l (major diastereomer) = 1.209  RF 2l (minor diastereomer) = 1.553 
 
Additive Area % 2la Area % 
std 
Area % 
additive 
RF 
additive:std 
Mass std 
(mg) 
GC yield 
of 2l 
Additive 
recovery 
None 
 
55.7 24.3 N/A N/A 5.0 80% N/A 
   36.8 18.3 31.6 1.065 4.6 64% 48% 
  
30.6 16.2 34.9 1.237 5.7 76% 87% 
  
36.8 16.8 22.5 2.426 5.3 80% 97% 
 
31.8 15.3 33.1 1.564 5.3 76% 101% 
1l 2l
Me
iPr
Ir[dF(CF3)ppy]2(dtbbpy)PF6(1 mol %)
ETCA (1.5 equiv)
additive (1.0 equiv)
CH2Cl2, 27 °C, 12 hblue LED
Me
iPr
O
O
OCs
O
Cl
Me
13
Me
9
O
Me
Me
5
Me
OH
Me
6
Br
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30.7 16.5 33.4 1.563 4.9 65% 90% 
 
33.4 19.2 28.2 1.914 5.7 70% 92% 
 
0.7 44.0 13.4 1.586 5.3 1% 15% 
 
39.0 18.1 35.3 1.954 4.6 69% 99% 
 
42.1 19.5 24.7 2.291 4.6 69% 75% 
 
38.9 17.1 30.1 1.761 4.9 79% 87% 
 
17.3 31.1 32.3 1.432 5.7 72% 87% 
 
0.6 37.2 ND ND 5.8 1% NDb 
 
58.0 31.9 3.9 3.598 5.8 74% 14% 
 
3.9 50.7 0.6 1.379 4.9 3% 0% 
 
2.9 52.1 3.7 1.279 5.8 2% 3% 
 
0.0 48.0 10.0 2.165 5.7 0% 15% 
 
0.0 21.1 32.7 1.377 4.6 0% 55% 
BF3OEt2  1.4 35.3 ND ND 4.9 2% ND 
 
49.0 31.8 ND ND 4.9 53% ND 
aArea % 2l = combined area of major and minor diastereomers of 2l 
bNot determined due to overlapping peaks in GC trace. 
Me
8
I
I
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t-Bu
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O Me
O
Me
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N t-Bu
N
H
N
N
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N
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Me Me
MeMe
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Me Me
MeMe
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6. Comparison with Non-Radical Deoxychlorination Processes. 
 
 
 
Method A (Radical deoxychlorination conditions; X=COCO2Cs): Experimental procedures listed 
in the above deoxychlorination reactions section. 
 
Method B (Appel reaction conditions; X=H): A 2 dram vial containing a stir bar was successively 
charged with alcohol substrate (0.1 mmol), triphenyl phosphine (52.5 mg, 0.2 mmol, 2.0 equiv), 
and CCl4 (0.33 mL). The vial was sealed and the reaction contents were stirred at 70 ºC for 14 h. 
The reaction was then cooled to room temperature and diluted with Et2O (2 mL). The resulting 
slurry was filtered through Celite, rinsed with Et2O (10 mL), and concentrated under rotary 
evaporation in a rotavap water bath at 27 °C (at a pressure of ~60–100 mmHg for volatile 
products). NMR yields were determined using quantitative 1H NMR spectroscopy with pyrazine 
as an added standard. 
 
Method C (SOCl2 conditions; X=H): A 2 dram vial containing a stir bar was successively charged 
with alcohol substrate (0.1 mmol) and CH2Cl2 (1.0 mL) and the contents were then placed under 
an argon atmosphere and cooled to 0 ºC. To the stirred solution was added SOCl2 (35 µL, 0.50 
mmol, 5.0 equiv) dropwise. The reaction was then allowed to warm to room temperature and 
stirred for 20 h. The reaction was slowly quenched with a 1:1 mixture of a saturated aqueous 
solution of NaCl and a saturated aqueous solution of NaHCO3 (1.0 mL) and then extracted with 
Et2O (4 x 3 mL). The combined organic extracts were dried over MgSO4, filtered, and concentrated 
X = COCO2Cs
method A: [Ir], ETCA, CH2Cl2
R1
R2
R3
OX
 X = H
method B: SOCl2, CH2Cl2
method C: PPh3, CCl4
R1
R2
R3
Cl
Ph
Me
Me
OX
Me Me
Me
MeH
OX
OPiv
O
Me Me
Me OX
Me
OX
Ph
Me
Me
Me
OX
H
Me
iPr
OX H
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under rotary evaporation in a rotavap water bath at 27 °C (at a pressure of ~60–100 mmHg for 
volatile products). NMR yields were determined using quantitative 1H NMR spectroscopy with 
pyrazine as an added standard. 
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7. Deoxybromination Reactions 
Optimization of Reaction Parameters 
 
  
 
Entrya Deviation from  
above conditions 
NMR yield 
11a (%)b 
1 None 66  
2 NBS  0 
3 CBr4  4 
4 1,1,2,2-tetrabromoethane  15 
5 
6 
7 
8 
9 
Ethyl tribromoacetate  
2-bromo-2-methyl propionic acid  
0.2 equiv Cs2CO3 
0.5 equiv Cs2CO3 
1.0 equiv C s2CO3 
9 
0 
80 
89 
64 
aPerformed on 37 mg (0.1 mmol) scale. 
bYields determined by quantitative 1H NMR spectrometry using pyrazine as a standard. 
 
General Procedure #4 (reaction optimization): On a benchtop, 1 dram vials each containing a 
stir bar were successively charged with cesium oxalate 1a (37 mg, 0.10 mmol, 1 equiv), 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1.1 mg, 0.001 mmol, 0.01 equiv), CH2Cl2 (0.5 mL) that was 
degassed by sparging with a balloon of argon for 15 min, and brominating agent (0.15 mmol, 1.5 
equiv). The vials were sparged with argon for an additional 10–15 seconds and then sealed with a 
screw cap under a stream of argon. The vials were subsequently irradiated with blue LED light for 
4 h in a Hepatochem device. Following this time, each of the vials was removed from the 
Hepatochem device. A 1:1 mixture of a saturated aqueous solution of NaCl and H2O (1.5 mL) was 
added to each vial and then each reaction was extracted with Et2O (3 x 3 mL). Each of the 
combined organic extracts was dried over MgSO4, filtered, and concentrated under rotary 
evaporation in a rotavap water bath at 27 °C (at a pressure of ~60–100 mmHg for volatile 
products). NMR yields were determined using quantitative 1H NMR spectroscopy with pyrazine 
as an added standard. The 1H NMR data for the tertiary bromide 11a was consistent with those 
reported in the literature.8 
 
OPh
Me Me O
OCs
O
1a 11a
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
diethyl bromomalonate
(1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
BrPh
Me Me
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General Procedure #5 (substrate scope): A 20 mL scintillation vial containing a stir bar was 
successively charged with cesium oxalate (1 equiv), Ir[dF(CF3)ppy]2(dtbbpy)PF6 (0.01 equiv), 
cesium carbonate (0.5 equiv), CH2Cl2 (1.5 mL) that was degassed by sparging with a balloon of 
argon for 15 min, and diethyl bromomalonate (1.5 equiv) were added. The vial was sparged with 
argon for an additional 10–15 seconds and then sealed with a screw cap under a stream of argon. 
The vial was placed in a Hepatochem device and irradiated with blue LED light. Tertiary alcohol-
derived cesium oxalates were irradiated for 4 h and secondary alcohol-derived cesium oxalates 
were irradiated for 24 h. The vial was subsequently removed from the Hepatochem device and 
transferred to a separatory funnel with a 1:1 mixture of a saturated aqueous solution of NaCl and 
H2O (1.5 mL) and then extracted with Et2O (3 x 3 mL). The combined organic extracts were dried 
over MgSO4, filtered, and concentrated under rotary evaporation in a rotavap water bath at 27 °C 
(at a pressure of ~60–100 mmHg for volatile products). The crude residue was purified by silica 
gel chromatography to afford the brominated products. To mitigate elimination of tertiary 
bromides to the corresponding alkenes during purification, silica gel columns were treated with 
Et3N as needed (see below).   
Bromides 11a and 11b were contaminated with diethyl bromomalonate and diethyl malonate 
following purification by column chromatography. For these products, the diethyl bromomalonate 
and diethyl malonate were removed by dissolving in THF (0.9 mL) and MeOH (0.45 mL), cooling 
to 0 ºC, and then adding a 3 M aqueous solution of NaOH (0.3 mL) dropwise. After stirring at 0 
ºC for 5 min and room temperature for 25 min, the solution was diluted with H2O (1 mL) and 
extracted with Et2O (4 x 2 mL). The combined organic extracts were dried over MgSO4, filtered, 
and concentrated under reduced pressure to afford the bromide products. 
 
  
(3-bromo-3-methylbutyl)benzene (11a): Prepared according to general procedure #5 using 
cesium oxalate 1a (111 mg, 0.30 mmol). A silica gel column was eluted with two column volumes 
of 3% Et3N/2% Et2O/pentane. The crude material was then purified using this column (isocratic: 
2% Et2O/pentane). Residual diethyl bromomalonate and diethylmalonate were removed by 
treatment with aqueous NaOH according to general procedure #5 to deliver bromide 11a as a pale 
yellow oil (57 mg, 83% yield). The 1H NMR data for tertiary bromide 11a was consistent with 
those reported in the literature.8  
OPh
Me Me O
OCs
O
1a 11a
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
Cs2CO3 (0.5 equiv)
diethyl bromomalonate
(1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
83% yield
BrPh
Me Me
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TLC Rf = 0.37 (hexanes, p-anisaldehyde). 
 
  
2-(2-((1r,4r)-1-bromo-4-(tert-butyl)cyclohexyl)ethyl)-1,3-dioxane (11b): Prepared according to 
general procedure #5 using cesium oxalate 1c (128 mg, 0.27 mmol). A silica gel column was eluted 
with two column volumes of 3% Et3N/5% Et2O/pentane. The crude material was then purified 
using this column (isocratic: 2% Et2O/pentane). Residual diethyl bromomalonate and 
diethylmalonate were removed by treatment with aqueous NaOH according to general procedure 
#5 to afford bromide 11b as a mixture of inseparable diastereomers as a clear colorless oil (75 mg, 
83% yield, 7.4:1 dr). 
TLC Rf = 0.28 (10% Et2O/hexanes, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 4.56 (t, J = 4.2 Hz, 1H), 4.10 (ddt, J = 10.4, 5.0, 1.4 Hz, 2H), 3.76 
(dddd, J = 11.9, 10.4, 2.6, 1.6 Hz, 2H), 2.18 – 2.08 (m, 2H), 2.08 – 2.00 (m, 1H), 1.98 – 1.85 (m, 
4H), 1.73 – 1.47 (m, 4H), 1.40 – 1.27 (m, 3H), 0.95 (tt, J = 11.9, 3.6 Hz, 1H), 0.86 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ 102.3, 76.6, 67.1, 47.6, 41.5, 41.4, 32.6, 31.2, 27.6, 25.9, 23.9. 
FTIR (NaCl, thin film, cm-1): 2948, 2849, 2729, 2657, 1446, 1366, 1286, 1248, 1147, 1079, 1040, 
1009, 974. 
HRMS (FAB+, m/z): calc’d for C16H28BrO2 (M+H–H2)+: 331.1273, found: 331.1251. 
 
  
7-benzyl-7-bromo-6,7,8,9-tetrahydro-5H-benzo[7]annulene (11c): Prepared according to 
general procedure #5 using cesium oxalate 1f (136 mg, 0.30 mmol). A silica gel column was eluted 
with two column volumes of 2% Et3N/pentane. The crude material was then purified using this 
column (isocratic: 2% Et2O/pentane) to provide bromide 11c as a viscous clear colorless oil (63 
1c 11b
tBu
Br
O
O
tBu
O
O
O
O
CsO
O
*
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
Cs2CO3 (0.5 equiv)
diethyl bromomalonate
(1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
83% yield
7.4:1 dr
1f 11c
Br
Ph
O
Ph
O
O
OCs
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
Cs2CO3 (0.5 equiv)
diethyl bromomalonate
(1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
67% yield
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mg, 67% yield). 
TLC Rf = 0.33 (3% Et2O/pentane, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) δ 7.30 – 7.22 (m, 5H), 7.09 (s, 4H), 3.46 – 3.31 (m, 2H), 3.29 (s, 
2H), 2.66 (dd, J = 14.9, 7.1 Hz, 2H), 2.33 (dddd, J = 14.9, 7.4, 2.3, 1.4 Hz, 2H), 1.83 – 1.56 (m, 
2H). 
13C NMR (101 MHz, CDCl3) δ 142.3, 136.4, 131.5, 129.1, 128.0, 127.1, 126.5, 80.3, 54.2, 41.9, 
32.6. 
FTIR (NaCl, thin film, cm-1): 3017, 2946, 1604, 1494, 1453, 1270, 1077, 1034, 936. 
HRMS (EI, m/z): calc’d for C18H18Br (M+H–H2)+: 313.0592, found: 313.0606. 
 
  
(1R,2S,4R)-2-bromo-1-isopropyl-4-methylcyclohexane (11d): Prepared according to general 
procedure #5 using cesium oxalate 1l (110 mg, 0.31 mmol). The crude residue was purified by 
silica gel chromatography (isocratic: 1% Et2O/pentane) to give bromide 11d as a clear colorless 
oil (44.1 mg, 66% yield, 10:1 dr). 
TLC Rf = 0.66 (pentane, p-anisaldehyde). 
[α]D25 = +36.2° (c = 1.00, CHCl3). 
1H NMR (major diastereomer, 400 MHz, CDCl3) δ 4.51 (tt, J = 7.2, 3.2 Hz, 1H), 2.11 – 1.94 (m, 
3H), 1.88 (ddt, J = 11.3, 7.6, 5.1 Hz, 1H), 1.81 – 1.72 (m, 1rH), 1.60 – 1.40 (m, 3H), 1.38 – 1.23 
(m, 1H), 0.93 (dd, J = 6.8, 2.3 Hz, 6H), 0.85 (d, J = 6.7 Hz, 3H). 
13C NMR (major diastereomer, 101 MHz, CDCl3) δ 57.4, 50.2, 41.9, 30.4, 28.9, 28.5, 21.2, 21.1, 
19.8, 18.3. 
FTIR (NaCl, thin film, cm-1): 2959, 1458, 1386, 1190, 1020, 974. 
HRMS (GC-EI, m/z): calc’d for C10H18Br (M–H)+: 217.0592, found: 217.0562. 
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Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol %)
Cs2CO3 (0.5 equiv)
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(1.5 equiv)
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66% yield
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*
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8. Deoxyfluorination Reactions 
General Procedure #6: In a nitrogen-filled glovebox, a 20 mL scintillation vial was charged with 
Selectfluor (1.5 equiv) and Cs2CO3 (0.5 equiv). The vial was sealed with a screw cap and removed 
from the glovebox. A stir bar was then added, followed by cesium oxalate (1.0 equiv) and 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (0.01 equiv). The vial was layered with argon for 45 seconds and 
CH2Cl2 (1.5 mL) was added (degassed by sparging with a balloon of argon for 20 min). The vial 
was sparged with argon for an additional 10–15 seconds and then sealed with a screw cap. The 
vial was placed in a Hepatochem device and irradiated with blue LED light. Tertiary alcohol-
derived cesium oxalates were irradiated for 4 h and secondary alcohol-derived cesium oxalates 
were irradiated for 24 h. Following this time, the reaction was removed from the Hepatochem 
device. The solid was removed by filtering through a pipette plug and rinsing with CH2Cl2 (15 
mL), and the solvent was removed under rotary evaporation. For volatile fluoride 12d, the reaction 
was performed in CD2Cl2 and a crude yield obtained directly using 1H NMR and pyrazine as an 
internal standard (no evaporation of solvent was performed). The crude residues were then purified 
by silica gel chromatography to afford the fluorinated products. To mitigate elimination of tertiary 
fluorides to the corresponding alkenes during purification, silica gel columns were pre-eluted with 
Et3N-containing solvent as needed for selected products (see below).  
 
 
2-((1R,4aS,8aS)-2-fluoro-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)ethyl pivalate 
(12a): 
Prepared according to general procedure #6 using cesium oxalate 1e (163 mg, 0.30 mmol).2 A 
silica gel column was pre-eluted with two column volumes of 3% Et3N/pentane, followed by two 
column volumes of pentane. Purification of the crude residue was then performed on this column 
(isocratic: 2% Et2O/pentane) to afford a 89:2:9 mixture of 12a (7.7:1 dr), SI-24, and SI-25 in (51 
mg, 50% yield: 45% 12a, 1% SI-24, 4% SI-25).  
TLC Rf = 0.37 (5% Et2O/pentane, p-anisaldehyde). 
[α]D25 = +9.9° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 4.13 – 4.03 (m, 2H), 1.98 (ddd, J = 12.3, 4.1, 3.0 Hz, 1H), 1.76 – 
1.50 (m, 6H), 1.51 – 1.36 (m, 3H), 1.34 (dd, J = 24.1, 1.1 Hz, 3H), 1.27 – 1.20 (m, 1H), 1.19 (s, 
9H), 1.16 – 1.06 (m, 1H), 1.04 – 0.89 (m, 2H), 0.88 (s, 3H), 0.78 (s, 3H), 0.78 (s, 3H). 
1e
7.7:1 dr
+ +
12a SI-24 SI-25
Me Me
Me
MeH
O
Me Me
Me
MeH
F
OPiv
O
OCs
O
OPiv
*
50% yield
89:2:9 ratio 10a/SI-24/SI-25
Me Me
Me
H
OPiv
Me
Me Me
Me
H
OPivIr[dF(CF3)2ppy]2(dtbbpy)PF6(1 mol%)
Cs2CO3 (0.5 equiv)
Selectfluor (1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
  S53 
13C NMR (101 MHz, CDCl3) δ 178.8, 98.5 (d, J = 166.5 Hz), 65.6 (d, J = 5.2 Hz), 55.8 (d, J = 1.9 
Hz), 55.4 (d, J = 17.4 Hz), 41.9, 41.1 (d, J = 20.7 Hz), 39.6, 38.8, 38.7 (d, J = 10.8 Hz), 33.5, 33.4, 
27.4, 24.4, 22.5 (d, J = 26.6 Hz), 21.6, 20.4 (d, J = 11.7 Hz), 18.5, 15.3. 
19F NMR (376 MHz, CDCl3) δ major diastereomer:-118.24 (qt, J = 24.2, 14.8 Hz), minor 
diastereomer: -156.64 – -157.46 (m). 
FTIR (NaCl, thin film, cm-1): 2955, 2870, 1728, 1459, 1284, 1157. 
HRMS (ESI+, m/z): calc’d for C21H37FO2 (M+Na)+: 363.2675, found: 363.2678. 
 
 
2-(2-((1r,4r)-4-(tert-butyl)-1-fluorocyclohexyl)ethyl)-1,3-dioxane (12b): 
Prepared according to general procedure #6 using cesium oxalate 1c (142 mg, 0.30 mmol). A silica 
gel column was pre-eluted with two column volumes of 3% Et3N/pentane, followed by two column 
volumes of pentane. Purification of the crude residue was then performed on this column (0–10% 
Et2O/pentane) to afford fluoride 12b as a clear oil (48.5 mg, 59% yield, 3:1 dr). 
TLC Rf (major diastereomer) = 0.48 (10% Et2O/pentane, p-anisaldehyde). 
TLC Rf (minor diastereomer) = 0.55 (90:20 pentane/Et2O, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3) major diastereomer: δ 4.52 (t, J = 4.8 Hz, 1H), 4.15 – 4.05 (m, 2H), 
3.81 – 3.70 (m, 2H), 2.15 – 2.00 (m, 1H), 1.98 – 1.86 (m, 2H), 1.83 – 1.64 (m, 4H), 1.65 – 1.52 
(m, 2H), 1.40 – 1.28 (m, 3H), 1.27 – 1.17 (m, 1H), 1.07 – 0.90 (m, 2fH), 0.85 (s, 9H). 
13C NMR (101 MHz, CDCl3) major diastereomer: δ 102.5, 94.9 (d, J = 169.9 Hz), 67.1, 47.5, 
36.1 (d, J = 20.3 Hz), 35.5 (d, J = 22.8 Hz), 35.1 (d, J = 23.2 Hz), 32.6, 29.0 (d, J = 4.7 Hz), 27.7, 
26.0, 24.7 (d, J = 11.9 Hz), 22.6. 
19F NMR (376 MHz, CDCl3) δ minor diastereomer: –138.26 (tt, J = 24.9, 12.8 Hz), major 
diastereomer: -161.48 – -162.22 (m). 
FTIR (NaCl, thin film, cm-1): 2949, 2848, 1469, 1366, 1240, 1148, 1007, 926. 
HRMS (FAB+, m/z): calc’d for C16H29FO2 (M+H–H2)–: 271.2073, found: 271.2084. 
 
59% yield
3:1 dr 12b1c
tBu
F
O
O
tBu
O
O
O
O
CsO
O
*
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol%)
Cs2CO3 (0.5 equiv)
Selectfluor (1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
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2-(2-((4aR,8aS)-1-fluorodecahydronaphthalen-1-yl)ethyl)-1,3-dioxane (12c): 
Prepared according to general procedure #6 using cesium oxalate 1d (142 mg, 0.30 mmol). A silica 
gel column (20 g) was pre-eluted with two column volumes of 3% Et3N/pentane, followed by two 
column volumes of 2% Et2O/pentane. The crude material was dry-loaded onto 400 mg celite, then 
purified using this column (2–10% Et2O/pentane) to afford a diastereomeric mixture of fluoride 
12c as a clear oil (26 mg, 32% yield, 1.25:1 dr). 
TLC Rf = 0.43 (20% Et2O/pentane, p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): Note: mixture of diastereomers: δ 4.57 – 4.50 (m, 1H), 4.50 (t, J = 
5.0 Hz, 1H), 4.15 – 4.05 (m, 4H), 3.81 – 3.68 (m, 4H), 2.15 – 1.99 (m, 3H), 1.90 – 1.49 (m, 23H), 
1.46 – 1.26 (m, 6H), 1.26 – 1.05 (m, 7H), 1.02 – 0.85 (m, 5H). 
13C NMR (101 MHz, CDCl3): Note: mixture of diastereomers: δ 102.7, 102.5, 98.6 (d, J = 172.4 
Hz), 97.1 (d, J = 172.4 Hz), 67.1, 52.0 (d, J = 19.0 Hz), 47.8 (d, J = 21.1 Hz), [aliphatic region: 
39.6, 39.5, 37.4, 35.0, 35.0, 34.8, 34.8, 34.68, 34.67, 33.80, 33.78, 33.76, 31.7, 31.4, 30.5, 29.9, 
29.8, 28.78, 28.75, 26.8, 26.5, 26.4, 26.2, 26.0, 25.9, 25.2, 25.2, 24.9, 24.83, 24.81, 24.7, 22.8, 
22.6, 21.28, 21.26]. 
19F NMR (376 MHz, CDCl3) δ -146.05 – -146.60 (m), -166.95 (tdd, J = 39.5, 19.5, 8.3 Hz). 
FTIR (NaCl, thin film, cm-1): 2928, 2851, 1449, 1376, 1146, 1002, 934. 
HRMS (FAB+, m/z): calc’d for C16H27FO2 (M+× – H)–: 269.1917, found: 269.1918. 
 
  
(1R,2S,4R)-2-fluoro-1-isopropyl-4-methylcyclohexane (12d): 
Prepared according to general procedure #6 using cesium oxalate 1l (108 mg, 0.30 mmol)2 and 
CD2Cl2 as a solvent. Fluoride 12d was formed in 31% yield (with 60% oxalate 1l remaining), 
1d 12c
H
H
F
O
OH
H
O
O
O
O
O
CsO
*
32% yield
1.25:1 dr
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol%)
Cs2CO3 (0.5 equiv)
Selectfluor (1.5 equiv)
CH2Cl2, 27 °C, 4 h, blue LED
31% yield by 1H NMR
10.7:1 dr
(60% 1l)
1l 12d
Me
iPr
Me
iPr
O
O
OCs
O
F
Ir[dF(CF3)2ppy]2(dtbbpy)PF6
(1 mol%)
Cs2CO3 (0.5 equiv)
Selectfluor (1.5 equiv)
CD2Cl2, 27 °C, 24 h, blue LED
*
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which was determined by 1H NMR with pyrazine as an internal standard. For characterization, the 
crude material in CD2Cl2 was loaded onto a silica gel column and purified using pentane (isocratic) 
to afford fluoride 12d as a clear oil (4 mg, 8% yield, 10.7:1 dr).  
TLC Rf = 0.65 (2% Et2O/pentane, p-anisaldehyde). 
[α]D25 = +17.4° (c = 0.20, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 4.70 (dtd, J = 47.8, 6.9, 3.3 Hz, 1H), 1.97 (dtd, J = 8.4, 4.8, 3.9, 
2.6 Hz, 1H), 1.83 (dq, J = 13.5, 6.7 Hz, 1H), 1.78 – 1.67 (m, 1H), 1.66 – 1.48 (m, 2H), 1.49 – 1.36 
(m, 3H), 1.29 – 1.16 (m, 1H), 0.92 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H), 0.91 – 0.88 (m, 
3H). 
13C NMR (101 MHz, CDCl3) δ 91.5 (d, J = 167.8 Hz), 47.0 (d, J = 16.8 Hz), 37.0 (d, J = 19.3 Hz), 
30.0 (d, J = 1.4 Hz), 27.7 (d, J = 6.8 Hz), 26.5 (d, J = 6.6 Hz), 20.9, 20.7 (d, J = 5.1 Hz), 20.5, 
19.3. 
19F NMR (376 MHz, CDCl3) δ -179.53 – -179.86 (m). 
FTIR (NaCl, thin film, cm-1): 2928, 2872, 1460, 1369, 1261, 1028. 
HRMS (EI+, m/z): calc’d for C10H19F (M+×)+: 158.1471, found: 158.1445. 
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Title DCG-5-295-1.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
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Experiment 1D
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Receiver Gain 156.2
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Data File Name / Volumes/ nmr/ DCG-5-295-1/ 3/
ﬁd
Title DCG-5-295-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 72.0
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Data File Name  JYS-2-136-F1-cyclopentyl-
acetal-Me-oxalate/ ﬁd
Title JYS-2-136-F1
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 34
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-04-18T18:55:19
Spectrometer
Frequency
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Data File Name  JYS-2-136-F1-cyclopentyl-acetal-Me-oxalate/ ﬁd
Title JYS-2-136-F1
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 256
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 4.6125
Acquisition Time 1.0420
Acquisition Date 2018-04-18T18:56:39
Spectrometer Frequency 125.65
Spectral Width 31446.5
Nucleus 13C
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Data File Name JYS-2-181-cyclopentyl-acetal-cs-ox/ 1/ ﬁd
Title JYS-2-181-cyclopentyl-acetal-cs-ox.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.1
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 78.7
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-02T07:18:52
Spectrometer Frequency 400.13
Spectral Width 8012.8
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Acquired Size 32768
Spectral Size 65536
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Data File Name JYS-2-181-cyclopentyl-acetal-cs-ox/ 2/ ﬁd
Title JYS-2-181-cyclopentyl-acetal-cs-ox.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-02T07:34:53
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
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Data File Name JYS-2-130-F1-tbu-cyclohexyl-acetal-maj-diast/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 22
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-04-17T00:12:04
Spectrometer Frequency 499.64
Spectral Width 8000.0
Nucleus 1H
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Spectral Size 65536
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Data File Name JYS-2-130-F1-tbu-cyclohexyl-acetal-maj-diast/ CARBON01.ﬁd/ ﬁd
Title CARBON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 256
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 4.6125
Acquisition Time 1.0420
Acquisition Date 2018-04-17T00:13:25
Spectrometer Frequency 125.65
Spectral Width 31446.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-4
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Data File Name JYS-2-130-F3-cyclohexyl-acetal-alcohol-minor-diast/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 32
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-04-18T17:36:03
Spectrometer Frequency 499.64
Spectral Width 8000.0
Nucleus 1H
Acquired Size 24000
Spectral Size 65536
SI-5
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Data File Name JYS-2-130-F3-cyclohexyl-acetal-alcohol-minor-diast/ CARBON01.ﬁd/ ﬁd
Title CARBON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 256
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 4.6125
Acquisition Time 1.0420
Acquisition Date 2018-04-18T17:37:24
Spectrometer Frequency 125.65
Spectral Width 31446.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-5
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Data File Name JYS-2-161-F1-tbu-cyclohexanol-acetal-Me-ox-maj-diast/ 1/ ﬁd
Title JYS-2-161-F1-tbu-cyclohexanol-acetal-Me-ox-maj-diast.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 64.2
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-21T09:14:20
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
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Data File Name JYS-2-161-F1-tbu-cyclohexanol-acetal-Me-ox-maj-diast/ 2/ ﬁd
Title JYS-2-161-F1-tbu-cyclohexanol-acetal-Me-ox-maj-diast.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-21T09:44:44
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-6
S68
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Data File Name JYS-2-166-tbucyclohexyl-acetal-cs-ox-majdiast-cd3od/ 1/ ﬁd
Title JYS-2-166-tbucyclohexyl-acetal-cs-ox-majdiast-cd3od.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 98.9
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-24T15:36:38
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
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Data File Name JYS-2-166-tbucyclohexyl-acetal-cs-ox-majdiast-cd3od/ 2/ ﬁd
Title JYS-2-166-tbucyclohexyl-acetal-cs-ox-majdiast-cd3od.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 55.5
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-24T15:45:02
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1c
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Data File Name JYS-2-162-F1-tbu-cyclohexanol-acetal-Me-ox-min-diast/ 1/ ﬁd
Title JYS-2-162-F1-tbu-cyclohexanol-acetal-Me-ox-min-diast.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-21T14:28:30
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
SI-7
S71
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
24
.1
25
.9
26
.4
27
.7
28
.8
32
.3
34
.6
47
.3
53
.4
67
.0
90
.0
10
2.
2
15
6.
6
15
9.
0
Parameter Value
Data File Name JYS-2-162-F1-tbu-cyclohexanol-acetal-Me-ox-min-diast/ 2/ ﬁd
Title JYS-2-162-F1-tbu-cyclohexanol-acetal-Me-ox-min-diast.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-21T14:58:15
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-7
S72
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
9.
76
3.
23
1.
32
2.
30
4.
05
1.
24
1.
97
2.
02
2.
18
2.
16
1.
00
0.
88
1.
13
1.
33
1.
57
1.
72
1.
99
2.
09
2.
28
3.
79
4.
03
4.
56
Parameter Value
Data File Name JYS-2-167-tbucyclohexyl-acetal-cs-ox-mindiast-cd3od/ 1/ ﬁd
Title JYS-2-167-tbucyclohexyl-acetal-cs-ox-mindiast-cd3od.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-24T15:59:01
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
1c'
S73
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
25
.0
27
.0
27
.2
28
.0
29
.8
33
.0
35
.9
67
.9
87
.2
10
3.
6
16
5.
9
16
6.
5
Parameter Value
Data File Name JYS-2-167-tbucyclohexyl-acetal-cs-ox-mindiast-cd3od/ 2/ ﬁd
Title JYS-2-167-tbucyclohexyl-acetal-cs-ox-mindiast-cd3od.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 50.3
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-24T16:14:12
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1c'
S74
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-272-1/ 1/ ﬁd
Title DCG-5-272-1.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 64.2
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-02T23:40:19
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
2.
88
1.
01
1.
86
3.
15
3.
18
7.
33
2.
08
1.
04
2.
08
2.
02
1.
00
0.
89
1.
05
1.
18
1.
32
1.
50
1.
60
1.
75
2.
06
3.
75
4.
09
4.
50
SI-8
S75
-100102030405060708090100110120130140150160170180190200210
ppm
21
.3
24
.9
25
.9
26
.3
26
.9
29
.7
34
.3
34
.6
34
.8
36
.7
37
.2
49
.0
67
.1
72
.4
10
2.
8
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-272-1/ 3/ ﬁd
Title DCG-5-272-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 50.3
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-03T00:00:42
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-8
S76
Parameter Value
Data File Name JYS-2-144-F1-decalin-acetal-Me-oxalate/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 26
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-04-18T21:46:47
Spectrometer Frequency 499.64
Spectral Width 8000.0
Nucleus 1H
Acquired Size 24000
Spectral Size 65536
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
2.
19
0.
99
11
.6
9
2.
10
2.
00
0.
99
0.
99
1.
00
1.
00
2.
09
2.
93
2.
01
1.
00
0.
93
1.
02
1.
34
1.
63
1.
75
1.
88
2.
06
2.
39
2.
66
3.
73
3.
86
4.
07
4.
47
SI-9
S77
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
21
.1
0
24
.6
9
25
.8
4
26
.1
0
26
.6
5
29
.3
8
30
.3
0
31
.9
0
33
.7
3
34
.6
3
36
.5
6
47
.8
1
53
.2
9
66
.9
9
67
.0
2
91
.1
9
10
2.
21
15
6.
82
15
9.
24
SI-9
Parameter Value
Data File Name JYS-2-144-F1-decalin-acetal-Me-oxalate/ CARBON01.ﬁd/ ﬁd
Title CARBON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 256
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 4.6125
Acquisition Time 1.0420
Acquisition Date 2018-04-18T21:48:08
Spectrometer Frequency 125.65
Spectral Width 31446.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S78
Parameter Value
Data File Name JYS-2-165-clean-decalin-acetal-cs-ox/ 1/ ﬁd
Title JYS-2-165-clean-decalin-acetal-cs-ox.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 98.9
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-01T05:32:07
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
3.
12
13
.3
7
2.
05
1.
00
1.
02
0.
99
1.
02
2.
03
2.
01
1.
00
0.
98
1.
43
1.
76
1.
87
1.
99
2.
40
2.
69
3.
78
4.
03
4.
51
1d
S79
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
22
.1
25
.6
27
.0
27
.2
27
.7
30
.4
31
.2
33
.2
35
.1
35
.9
37
.56
7.
9
88
.6
10
3.
5
16
6.
8
16
7.
3
1d
Parameter Value
Data File Name JYS-2-165-clean-decalin-acetal-cs-ox/ 2/ ﬁd
Title JYS-2-165-clean-decalin-acetal-cs-ox.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent MeOD
Temperature 295.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 55.5
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-01T05:47:50
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S80
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
04
2.
17
2.
01
1.
93
2.
00
1.
95
3.
96
1.
98
3.
24
1.
36
1.
58
1.
80
2.
49
2.
74
3.
17
7.
09
7.
19
7.
26
SI-11
Parameter Value
Data File Name JYS-1-148-F3-cycloheptyl-Bn-alcohol-clean copy/ 1/ ﬁd
Title JYS-1-148-F3-cycloheptyl-Bn-alcohol-clean.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 50.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-01T01:49:23
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S81
-100102030405060708090100110120130140150160170180190200
ppm
29
.6
39
.1
50
.8
73
.6
12
6.
3
12
6.
7
12
8.
4
12
8.
8
13
0.
9
13
6.
9
14
2.
9
SI-11
Parameter Value
Data File Name JYS-1-148-F3-cycloheptyl-Bn-alcohol-clean copy/ 2/ ﬁd
Title JYS-1-148-F3-cycloheptyl-Bn-alcohol-clean.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-01T02:19:07
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S82
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
2.
22
2.
05
2.
01
2.
02
2.
00
3.
00
3.
84
2.
16
3.
39
1.
60
2.
56
2.
67
3.
08
3.
31
3.
89
7.
10
7.
13
7.
25
SI-12
Parameter Value
Data File Name JYS-1-230-F1-cycloheptyl-Bn-Me-oxalate/ 1/ ﬁd
Title JYS-1-230-F1-cycloheptyl-Bn-Me-oxalate.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 72.0
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-01T02:23:58
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S83
-100102030405060708090100110120130140150160170180190200
ppm
29
.335
.9
45
.0
53
.5
91
.2
12
6.
5
12
7.
0
12
8.
4
12
9.
0
13
0.
7
13
5.
7
14
2.
1
15
7.
3
15
9.
0
SI-12
Parameter Value
Data File Name JYS-1-230-F1-cycloheptyl-Bn-Me-oxalate/ 2/ ﬁd
Title JYS-1-230-F1-cycloheptyl-Bn-Me-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-01T02:53:43
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S84
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
94
3.
85
2.
01
2.
00
4.
10
5.
15
1.
33
2.
43
3.
01
3.
20
7.
05
7.
20
1f
Parameter Value
Data File Name JYS-1-261-cycloheptyl-Bn-Cs-oxalate/ 4/ ﬁd
Title JYS-1-261-cycloheptyl-Bn-Cs-oxalate.4.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 176.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-08T20:05:06
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S85
-100102030405060708090100110120130140150160170180190200
ppm
28
.4
35
.8
44
.183
.7
12
6.
0
12
6.
2
12
7.
8
12
8.
5
13
0.
7
13
6.
9
14
2.
4
16
3.
3
16
7.
9
1f
Parameter Value
Data File Name JYS-1-261-cycloheptyl-Bn-Cs-oxalate/ 2/ ﬁd
Title JYS-1-261-cycloheptyl-Bn-Cs-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-07T00:22:55
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S86
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
13
1.
92
2.
06
2.
07
2.
01
1.
19
0.
88
1.
97
1.
83
2.
06
2.
05
1.
00
3.
92
1.
33
1.
51
1.
61
1.
74
1.
83
2.
09
2.
30
2.
51
3.
18
3.
78
4.
11
4.
57
7.
10
SI-13
Parameter Value
Data File Name JYS-1-185-F3-cycloheptyl-acetal-alcohol/ 1/ ﬁd
Title JYS-1-185-F3-cycloheptyl-acetal-alcohol.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-03T08:17:10
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S87
-100102030405060708090100110120130140150160170180190200
ppm
25
.7
5
29
.0
5
29
.6
9
37
.9
6
39
.2
1
67
.0
5
72
.9
5
10
2.
61
12
6.
15
12
8.
76
14
3.
07
SI-13
Parameter Value
Data File Name JYS-1-185-F3-cycloheptyl-acetal-alcohol/ 2/ ﬁd
Title JYS-1-185-F3-cycloheptyl-acetal-alcohol.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-03T08:46:54
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S88
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
15
3.
91
2.
97
3.
88
1.
99
2.
02
3.
03
2.
03
1.
00
3.
98
1.
31
1.
60
2.
07
2.
58
3.
07
3.
72
3.
88
4.
06
4.
48
7.
10
SI-14
Parameter Value
Data File Name JYS-1-187-B-F1-cycloheptyl-acetal-Me-oxalate/ 1/ ﬁd
Title JYS-1-187-B-F1-cycloheptyl-acetal-Me-oxalate.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-03T08:51:17
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S89
-100102030405060708090100110120130140150160170180190200
ppm
25
.8
29
.2
29
.4
32
.9
36
.0
53
.5
67
.0
91
.2
10
2.
0
12
6.
5
12
9.
0
14
2.
1
15
6.
6
15
8.
9
SI-14
Parameter Value
Data File Name JYS-1-187-B-F1-cycloheptyl-acetal-Me-oxalate/ 2/ ﬁd
Title JYS-1-187-B-F1-cycloheptyl-acetal-Me-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 50.3
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-03T09:21:05
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S90
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
5.
14
2.
99
1.
89
2.
05
2.
02
2.
05
2.
05
1.
00
4.
23
1.
50
1.
97
2.
46
2.
55
2.
97
3.
83
4.
04
4.
66
7.
15
1g
Parameter Value
Data File Name JYS-1-196-cycloheptyl-acetal-Cs-oxalate/ 1/ ﬁd
Title JYS-1-196-cycloheptyl-acetal-Cs-oxalate.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-03T09:27:25
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S91
-100102030405060708090100110120130140150160170180190200
ppm
27
.6
30
.9
31
.1
34
.6
38
.0
69
.5
91
.9
10
4.
6
12
9.
1
13
1.
4
14
5.
2
16
6.
5
16
7.
5
1g
Parameter Value
Data File Name JYS-1-196-cycloheptyl-acetal-Cs-oxalate/ 2/ ﬁd
Title JYS-1-196-cycloheptyl-acetal-Cs-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-03T09:57:47
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S92
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
02
1.
14
13
.8
4
3.
43
1.
00
1.
00
3.
02
1.
98
0.
93
1.
10
1.
73
2.
06
2.
56
2.
92
7.
23
7.
30
SI-15
Parameter Value
Data File Name JYS-1-120-F1-adamantyl-bn-alcohol-clean/ 1/ ﬁd
Title JYS-1-120-F1-adamantyl-bn-alcohol-clean.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-01T00:53:44
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S93
-100102030405060708090100110120130140150160170180190200
ppm
20
.8
0
28
.8
5
36
.4
2
37
.3
1
39
.3
1
41
.1
3
75
.7
6
12
6.
25
12
8.
10
13
1.
22
13
8.
69
SI-15
Parameter Value
Data File Name JYS-1-120-F1-adamantyl-bn-alcohol-clean/ 2/ ﬁd
Title JYS-1-120-F1-adamantyl-bn-alcohol-clean.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-01T01:08:52
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S94
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
20
10
.8
6
3.
38
3.
49
1.
00
1.
02
3.
05
5.
82
1.
48
1.
71
1.
86
2.
06
2.
75
3.
32
3.
89
7.
23
SI-16
Parameter Value
Data File Name JYS-1-123-F2-adamantyl-Bn-Me-oxalate-clean/ 1/ ﬁd
Title JYS-1-123-F2-adamantyl-Bn-Me-oxalate-clean.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 55.5
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-01T01:13:48
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S95
-100102030405060708090100110120130140150160170180190200
ppm
18
.6
28
.6
36
.9
37
.0
40
.9
41
.4
53
.4
96
.0
12
6.
6
12
8.
1
13
1.
1
13
7.
4
15
6.
9
15
9.
3
SI-16
Parameter Value
Data File Name JYS-1-123-F2-adamantyl-Bn-Me-oxalate-clean/ 2/ ﬁd
Title JYS-1-123-F2-adamantyl-Bn-Me-oxalate-clean.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-01T01:44:33
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S96
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
17
10
.5
2
3.
10
3.
37
0.
98
1.
00
1.
15
2.
40
2.
06
1.
22
1.
62
1.
75
1.
95
2.
78
3.
14
7.
15
7.
20
7.
31
1h
Parameter Value
Data File Name JYS-1-202/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent DMSO
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 42
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2017-08-09T12:21:55
Spectrometer Frequency 499.65
Spectral Width 8000.0
Nucleus 1H
Acquired Size 24000
Spectral Size 65536
S97
-100102030405060708090100110120130140150160170180190200
ppm
19
.4
28
.1
36
.1
36
.6
40
.7
88
.3
12
5.
8
12
7.
7
13
0.
8
13
8.
8
16
3.
7
16
7.
8
1h
Parameter Value
Data File Name JYS-1-202-adamantyl-Bn-Cs-oxalate/ 2/ ﬁd
Title JYS-1-202-adamantyl-Bn-Cs-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 50.3
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-06T23:11:58
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S98
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
2.
00
6.
92
3.
09
1.
08
0.
98
0.
99
0.
98
1.
00
0.
95
0.
38
0.
93
0.
94
0.
95
0.
99
1.
30
1.
91
2.
11
2.
49
4.
87
6.
78
SI-18
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-60-C/ 1/ ﬁd
Title DCG-5-60-C.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 176.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-07-25T17:40:58
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S99
-100102030405060708090100110120130140150160170180190200210
ppm
14
.6
15
.3
19
.7
20
.2
27
.9
30
.0
31
.1
33
.1
35
.9
79
.8
15
7.
7
15
7.
8
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-60-C/ 3/ ﬁd
Title DCG-5-60-C.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 1.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-07-25T18:14:06
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-18
S100
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
00
1.
02
3.
03
4.
14
3.
14
1.
11
1.
00
0.
99
1.
00
1.
00
0.
25
0.
39
0.
78
0.
86
0.
88
0.
92
1.
27
1.
65
1.
86
2.
26
4.
53
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-61-S/ 2/ ﬁd
Title DCG-5-61-S.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-07-26T15:29:59
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
1k
S101
-100102030405060708090100110120130140150160170180190200210
ppm
13
.8
15
.1
19
.5
20
.1
27
.5
29
.6
30
.3
32
.4
35
.1
72
.6
16
2.
8
16
7.
2
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-61-S/ 4/ ﬁd
Title DCG-5-61-S.4.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-07-26T16:12:22
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1k
S102
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
05
7.
20
0.
99
1.
08
1.
99
2.
01
1.
00
1.
01
1.
00
0.
12
0.
76
0.
89
0.
90
0.
93
1.
07
1.
19
1.
55
1.
72
1.
88
2.
05
4.
87
6.
08
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-180-C/ 1/ ﬁd
Title DCG-5-180-C.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 176.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-20T19:58:32
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
SI-19
S103
-100102030405060708090100110120130140150160170180190200
ppm
16
.3
20
.7
22
.0
23
.4
26
.3
31
.6
34
.0
40
.3
46
.7
79
.7
15
7.
5
15
8.
0
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-180-C/ 2/ ﬁd
Title DCG-5-180-C.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-20T20:14:14
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-19
S104
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
03
7.
07
2.
02
2.
00
2.
02
1.
01
1.
00
1.
01
0.
72
0.
84
0.
86
0.
88
1.
09
1.
49
1.
68
1.
80
1.
94
4.
75
Parameter Value
Data File Name / Volumes/ nmrdata/ dgrunenf/ nmr/ DCG-5-181-S/ 1/ ﬁd
Title DCG-5-181-S.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-21T15:09:13
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
1m
S105
-100102030405060708090100110120130140150160170180190200210
ppm
18
.4
22
.5
24
.0
25
.8
28
.6
33
.7
36
.3
42
.6
49
.1
80
.0
16
7.
2
16
7.
3
Parameter Value
Data File Name / Volumes/ nmrdata/ dgrunenf/ nmr/ DCG-5-181-S/ 2/ ﬁd
Title DCG-5-181-S.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-21T15:24:54
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1m
S106
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
24
3.
31
4.
42
1.
16
1.
14
1.
22
2.
17
1.
13
3.
30
1.
05
0.
81
1.
07
1.
12
1.
22
1.
48
1.
60
1.
71
1.
82
3.
89
4.
49
Parameter Value
Data File Name JYS-1-180-F1-fenchyl-Me-oxalate/ 1/ ﬁd
Title JYS-1-180-F1-fenchyl-Me-oxalate.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-04T18:15:04
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
SI-20
S107
-100102030405060708090100110120130140150160170180190200
ppm
19
.4
20
.2
25
.9
26
.6
29
.8
39
.9
41
.54
8.
4
48
.6
53
.5
89
.6
15
8.
4
15
8.
7
SI-20
Parameter Value
Data File Name JYS-1-180-F1-fenchyl-Me-oxalate/ 2/ ﬁd
Title JYS-1-180-F1-fenchyl-Me-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-04T18:44:48
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S108
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
2.
87
3.
13
3.
75
1.
06
1.
05
3.
98
1.
00
0.
71
0.
99
1.
03
1.
13
1.
40
1.
63
4.
17
1n
Parameter Value
Data File Name JYS-1-257-fenchyl-Cs-oxalate/ 1/ ﬁd
Title JYS-1-257-fenchyl-Cs-oxalate.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-04T18:49:52
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S109
-100102030405060708090100110120130140150160170180190200
ppm
19
.3
6
20
.0
7
25
.5
3
26
.2
1
29
.5
4
40
.8
7
47
.7
8
47
.8
0
83
.6
0
16
3.
06
16
8.
19
Parameter Value
Data File Name JYS-1-257-fenchyl-Cs-oxalate/ 2/ ﬁd
Title JYS-1-257-fenchyl-Cs-oxalate.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent DMSO
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-04T19:20:11
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1n
S110
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
02
3.
18
3.
12
1.
17
2.
15
1.
20
1.
18
0.
89
0.
99
1.
00
1.
23
1.
12
1.
26
1.
33
1.
42
1.
61
1.
70
1.
97
2.
04
2.
69
4.
88
9.
01
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-160-C/ 1/ ﬁd
Title DCG-5-160-C.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 78.7
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-03T12:30:06
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
SI-22
S111
-100102030405060708090100110120130140150160170180190200210
ppm
21
.8
23
.9
25
.7
28
.4
28
.7
32
.1
33
.9
71
.6
75
.1
76
.3
15
8.
0
15
8.
3
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-160-C/ 3/ ﬁd
Title DCG-5-160-C.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-03T12:49:51
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
SI-22
S112
-3-2-1012345678910111213141516
ppm
3.
00
3.
07
2.
99
1.
13
3.
09
2.
11
1.
00
1.
00
1.
05
1.
23
1.
30
1.
45
1.
61
1.
98
2.
64
4.
75
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-161-S/ 1/ ﬁd
Title DCG-5-161-S.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 142.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-04T21:05:25
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
1o
S113
-100102030405060708090100110120130140150160170180190200210
ppm
23
.5
25
.8
27
.9
30
.2
30
.6
33
.9
35
.974
.7
77
.1
78
.5
16
7.
0
16
7.
1
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-161-S/ 5/ ﬁd
Title DCG-5-161-S.5.ﬁd
Origin Bruker BioSpin GmbH
Solvent D2O
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-04T22:22:11
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
1o
S114
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
6.
01
1.
97
2.
00
2.
93
1.
95
1.
66
2.
06
2.
84
7.
21
7.
30
Parameter Value
Data File Name JYS-2-205-C-F1-NaOH-model-chloride/1/ﬁd
Title JYS-2-205-C-F1-NaOH-model-chloride.1.ﬁd
Origin Varian
Solvent cdcl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 34
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-07-14T20:30:57
Spectrometer Frequency 499.64
Spectral Width 8000.0
Nucleus 1H
Acquired Size 24000
Spectral Size 65536
2a
S115
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
1.
10
4.
28
6.
20
3.
29
0.
35
0.
12
2.
19
2.
14
0.
07
1.
00
0.
06
1.
32
1.
69
1.
91
2.
07
2.
25
3.
10
3.
75
4.
08
4.
50
4.
55
5.
31
Parameter Value
Data File Name JYS-2-185-F1-NaOH-cyclopentyl-acetal-chloride/ 1/ ﬁd
Title JYS-2-185-F1-NaOH-cyclopentyl-acetal-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-17T05:35:42
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2b
SI-22 94	:	6
ratio
S116
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
23
.2
25
.9
31
.9
37
.5
42
.4
67
.0
82
.7
10
2.
1
Parameter Value
Data File Name JYS-2-185-F1-NaOH-cyclopentyl-acetal-chloride/ 2/ ﬁd
Title JYS-2-185-F1-NaOH-cyclopentyl-acetal-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-17T06:05:27
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2b
SI-22 94	:	6
ratio
S117
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
0.
86
8.
34
1.
23
5.
14
2.
43
4.
45
1.
95
1.
21
2.
06
2.
05
1.
00
0.
83
0.
86
0.
93
1.
41
1.
61
1.
83
1.
99
2.
09
3.
76
4.
09
4.
55
Parameter Value
Data File Name JYS-2-127-F1-tbu-cyclohexyl-acetal-chloride/ 1/ ﬁd
Title JYS-2-127-F1-tbu-cyclohexyl-acetal-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-26T03:13:14
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2c
9.8:1	dr
0.810.820.830.840.850.860.870.88
f1 (ppm)
0.
86
8.
34
1.
23
0.
83
0.
86
S118
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
23
.0
25
.9
27
.7
30
.0
32
.6
40
.1
40
.2
47
.7
67
.1
75
.5
10
2.
4
Parameter Value
Data File Name JYS-2-127-F1-tbu-cyclohexyl-acetal-chloride/ 2/ ﬁd
Title JYS-2-127-F1-tbu-cyclohexyl-acetal-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-26T03:43:44
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2c
9.8:1	dr
S119
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
4.
34
7.
68
9.
61
6.
36
1.
64
2.
77
0.
46
2.
69
2.
70
1.
00
0.
32
0.
95
1.
25
1.
53
1.
76
1.
93
2.
07
2.
23
3.
75
4.
09
4.
51
4.
53
Parameter Value
Data File Name JYS-2-147-F1-decalin-acetal-chloride/ 1/ ﬁd
Title JYS-2-147-F1-decalin-acetal-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 50.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-04-27T01:16:46
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2d
2.9:1	dr
S120
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
21
.8
6
23
.2
7
25
.9
1
25
.9
3
26
.0
7
26
.3
0
26
.5
5
26
.7
2
26
.8
7
28
.0
7
29
.8
7
30
.1
7
33
.9
2
33
.9
9
34
.5
9
34
.9
9
37
.0
3
38
.8
9
39
.8
1
40
.5
4
51
.0
8
55
.8
4
67
.0
6
78
.9
9
79
.7
6
10
2.
43
10
2.
54
Parameter Value
Data File Name JYS-2-147-F1-decalin-acetal-chloride/ 2/ ﬁd
Title JYS-2-147-F1-decalin-acetal-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-04-27T01:46:31
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2d
2.9:1	dr
S121
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
0.
22
2.
81
3.
82
3.
77
2.
91
12
.1
4
4.
55
4.
48
4.
27
1.
33
0.
99
0.
23
0.
86
1.
34
1.
00
0.
06
0.
06
0.
02
0.
67
0.
77
0.
82
0.
86
0.
98
1.
20
1.
39
1.
56
1.
69
1.
83
2.
05
2.
18
2.
26
4.
05
4.
17
4.
56
4.
83
5.
42
Parameter Value
Data File Name sclareolide-chloride-JYS-2-35-F1/ 1/ ﬁd
Title JYS-2-35-F1-sclareolide-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 15.9
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-21T08:55:57
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2e																										SI-23
SI-24
5.9:1	dr92	:	4	:	6	ratio
4.04.24.44.64.85.05.25.4
ppm
1.
34
1.
00
0.
06
0.
06
0.
02
4.
05
4.
17
4.
56
4.
83
5.
42
S122
-100102030405060708090100110120130140150160170180190200
ppm
15
.5
4
15
.7
2
18
.1
9
18
.4
2
18
.8
4
21
.1
2
21
.5
8
21
.7
8
26
.2
3
26
.3
7
26
.9
1
27
.4
0
33
.3
4
33
.3
7
33
.5
3
34
.2
7
38
.8
2
38
.8
3
39
.3
7
39
.6
5
39
.8
9
40
.7
4
41
.8
5
41
.9
7
45
.2
0
46
.5
4
55
.9
8
56
.1
2
57
.2
2
58
.9
1
66
.0
3
66
.4
4
75
.7
0
78
.0
3
17
8.
80
17
8.
83
Parameter Value
Data File Name sclareolide-chloride-JYS-2-35-F1/ 2/ ﬁd
Title JYS-2-35-F1-sclareolide-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 50.3
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-21T09:26:43
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2e																										SI-23
SI-24
5.9:1	dr92	:	4	:	6	ratio
S123
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
95
1.
98
1.
94
2.
00
1.
93
3.
91
5.
05
1.
73
2.
16
2.
61
3.
10
3.
33
7.
10
7.
27
Parameter Value
Data File Name JYS-1-263-F1-cycloheptyl-Bn-chloride/ 1/ ﬁd
Title JYS-1-263-F1-cycloheptyl-Bn-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-07T00:28:34
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2f
S124
-100102030405060708090100110120130140150160170180190200
ppm
31
.0
41
.0
53
.0
78
.9
12
6.
4
12
7.
0
12
8.
0
12
9.
0
13
1.
4
13
6.
1
14
2.
4
Parameter Value
Data File Name JYS-1-263-F1-cycloheptyl-Bn-chloride/ 2/ ﬁd
Title JYS-1-263-F1-cycloheptyl-Bn-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-07T00:58:52
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2f
S125
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
36
1.
96
4.
04
1.
16
2.
03
2.
00
1.
85
2.
03
2.
03
1.
00
4.
01
1.
33
1.
68
1.
87
2.
07
2.
19
2.
61
3.
29
3.
76
4.
09
4.
55
7.
12
Parameter Value
Data File Name JYS-1-208-F2-cycloheptyl-acetal-chloride/ 1/ ﬁd
Title JYS-1-208-F2-cycloheptyl-acetal-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-06T23:17:29
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2g
S126
-100102030405060708090100110120130140150160170180190200
ppm
25
.9
30
.1
31
.0
41
.1
67
.0
79
.1
10
2.
2
12
6.
4
12
8.
9
14
2.
4
Parameter Value
Data File Name JYS-1-208-F2-cycloheptyl-acetal-chloride/ 2/ ﬁd
Title JYS-1-208-F2-cycloheptyl-acetal-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-06T23:47:49
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2g
S127
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
59
10
.1
4
6.
32
3.
90
1.
02
1.
00
0.
19
0.
10
0.
10
0.
07
0.
02
0.
51
5.
94
1.
40
1.
82
1.
99
2.
18
3.
00
3.
28
3.
48
7.
26
7.
37
Parameter Value
Data File Name adamantyl-bn-chloride-JYS-1-274-F1/ 1/ ﬁd
Title JYS-1-274-F1-adamantyl-bn-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-19T20:27:43
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
85	:	8	:	7	ratio
2h																											SI-25
SI-26
S128
-100102030405060708090100110120130140150160170180190200
ppm
23
.1
28
.9
37
.0
37
.1
41
.2
43
.0
82
.6
12
6.
6
12
7.
7
13
1.
8
13
7.
8
Parameter Value
Data File Name adamantyl-bn-chloride-JYS-1-274-F1/ 2/ ﬁd
Title JYS-1-274-F1-adamantyl-bn-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-19T20:57:28
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2h																											SI-25
SI-26 85	:	8	:	7	ratio
S129
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
16
6.
17
1.
22
3.
17
0.
99
1.
07
1.
03
1.
00
1.
34
1.
55
1.
73
1.
91
3.
98
4.
99
5.
16
5.
84
Parameter Value
Data File Name JYS-2-21-linalool-chloride/ 1/ ﬁd
Title JYS-2-21-linalool-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 50.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-10-28T19:12:03
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2i
S130
-100102030405060708090100110120130140150160170180190200
ppm
26
.7
27
.7
27
.8
29
.937
.1
71
.5
84
.1
85
.8
11
1.
6
14
3.
5
Parameter Value
Data File Name JYS-2-21-linalool-chloride/ 2/ ﬁd
Title JYS-2-21-linalool-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-10-28T19:41:47
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2i
S131
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
4.
18
2.
20
1.
03
1.
03
1.
04
0.
93
0.
91
5.
03
1.
66
1.
82
2.
00
3.
24
3.
45
3.
63
4.
58
7.
39
Parameter Value
Data File Name Bz-piperidine-chloride-JYS-1-226-F1/ 1/ ﬁd
Title JYS-1-226-F1-Bz-piperidine-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 72.0
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-10T01:23:46
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
2j
S132
-100102030405060708090100110120130140150160170180190200
ppm
33
.4
38
.8
40
.3
41
.2
44
.5
69
.3
12
7.
0
12
8.
6
12
9.
8
13
6.
0
17
0.
5
Parameter Value
Data File Name Bz-piperidine-chloride-JYS-1-226-F1/ 2/ ﬁd
Title JYS-1-226-F1-Bz-piperidine-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-10T01:53:31
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2j
S133
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
0.
07
0.
05
1.
04
1.
29
7.
91
0.
21
3.
20
1.
59
1.
07
1.
01
0.
06
1.
08
1.
00
0.
04
0.
41
0.
57
0.
85
0.
92
1.
06
1.
26
1.
78
2.
16
2.
37
3.
87
2k
20:1	dr
Parameter Value
Data File Name thujol-chloride-JYS-1-203-F1/ 1/ ﬁd
Title JYS-1-203-F1-thujol-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-19T13:11:11
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S134
-100102030405060708090100110120130140150160170180190200
ppm
19
.0
19
.9
20
.3
20
.7
29
.9
33
.1
35
.2
38
.0
47
.2
65
.7
Parameter Value
Data File Name thujol-chloride-JYS-1-203-F1/ 2/ ﬁd
Title JYS-1-203-F1-thujol-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-19T13:40:56
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2k
20:1	dr
S135
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
58
6.
68
2.
35
3.
87
1.
34
1.
93
2.
13
1.
00
0.
05
0.
85
0.
92
1.
25
1.
46
1.
72
1.
82
2.
03
4.
26
4.
43
2l
20:1	dr
Parameter Value
Data File Name isomenthyl-chloride-JYS-1-142-A-F1/ 1/ ﬁd
Title JYS-1-142-A-F1-isomenthyl-chloride.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 64.2
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-18T08:17:54
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S136
-100102030405060708090100110120130140150160170180190200
ppm
18
.2
19
.9
20
.5
21
.1
27
.4
28
.0
30
.3
41
.1
49
.9
62
.0
2l
20:1	dr
Parameter Value
Data File Name isomenthyl-chloride-JYS-1-142-A-F1/ 2/ ﬁd
Title JYS-1-142-A-F1-isomenthyl-chloride.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-18T08:47:38
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S137
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
3.
08
23
.5
6
2.
51
6.
66
2.
06
5.
26
1.
54
1.
51
0.
99
1.
04
1.
00
1.
52
0.
78
0.
91
1.
04
1.
37
1.
55
1.
72
1.
90
2.
05
2.
22
2.
34
3.
79
4.
51
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-109-1/ 2/ ﬁd
Title DCG-5-109-1.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zg30
Experiment 1D
Number of Scans 1
Receiver Gain 30.3
Relaxation Delay 10.0000
Pulse Width 11.7000
Acquisition Time 9.9998
Acquisition Date 2017-09-21T12:28:44
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 80127
Spectral Size 262144
2m
1.5:1	dr
S138
-100102030405060708090100110120130140150160170180190200210
15
.2
6
20
.3
2
20
.9
4
21
.1
4
22
.0
2
22
.0
7
24
.3
8
24
.4
0
26
.0
1
27
.2
6
30
.2
0
33
.5
1
34
.3
7
34
.9
6
43
.4
1
46
.8
7
49
.0
8
50
.5
5
63
.5
7
64
.0
7
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-109-1/ 3/ ﬁd
Title DCG-5-109-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-09-21T12:36:34
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
2m
1.5:1	dr
S139
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
45
4.
71
4.
39
3.
36
1.
61
1.
50
3.
11
2.
36
1.
00
0.
15
0.
96
1.
04
1.
09
1.
16
1.
23
1.
41
1.
60
1.
80
3.
50
3.
62
Parameter Value
Data File Name JYS-2-36-F1-QNMR/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 1
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 5.1000
Acquisition Time 5.0000
Acquisition Date 2017-11-08T15:37:57
Spectrometer Frequency 300.09
Spectral Width 4796.2
Nucleus 1H
Acquired Size 23981
Spectral Size 65536
2n
6.7:1	dr
3.43.53.63.73.8
ppm
1.
00
0.
15
3.
50
3.
62
S140
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
00
1.
34
0.
86
2.
71
3.
92
8.
58
Parameter Value
Data File Name JYS-2-50-crude-QNMR/ PROTON01.ﬁd/ ﬁd
Title PROTON01
Origin Varian
Solvent CDCl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 1
Receiver Gain 0
Relaxation Delay 1.0000
Pulse Width 5.1000
Acquisition Time 6.0000
Acquisition Date 2017-11-20T18:17:50
Spectrometer Frequency 300.09
Spectral Width 4796.2
Nucleus 1H
Acquired Size 28777
Spectral Size 65536
*pyrazine
standard
2o
2.9:1	dr
2.62.83.03.23.43.63.84.0
ppm
1.
00
1.
34
2.
71
3.
92
S141
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
03
3.
11
3.
27
3.
27
1.
06
0.
40
2.
06
1.
00
1.
18
1.
17
1.
20
1.
28
1.
61
1.
80
1.
90
2.
05
2.
74
3.
93
2o
isolated major
diastereomer
Parameter Value
Data File Name eucalyptol-chloride-maj-diast-JYS-2-50-F1/ 1/ ﬁd
Title JYS-2-50-F1-eucalyptol-chloride-maj-diast.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 294.9
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 112.8
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2017-11-28T21:17:36
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S142
-100102030405060708090100110120130140150160170180190200
ppm
21
.9
25
.2
25
.4
28
.4
28
.9
34
.6
36
.3
59
.7
73
.5
74
.2
2o
isolated major
diastereomer
Parameter Value
Data File Name eucalyptol-chloride-maj-diast-JYS-2-50-F1/ 2/ ﬁd
Title JYS-2-50-F1-eucalyptol-chloride-maj-diast.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.0
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-11-28T21:47:20
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S143
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
6.
10
2.
01
2.
00
2.
98
2.
00
1.
84
2.
10
2.
87
7.
21
7.
30
Parameter Value
Data File Name JYS-2-179-C-NaOH-F1-model-bromide/1/ﬁd
Title JYS-2-179-C-NaOH-F1-model-bromide.1.ﬁd
Origin Varian
Solvent cdcl3
Temperature 25.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 34
Relaxation Delay 1.0000
Pulse Width 5.8000
Acquisition Time 3.0000
Acquisition Date 2018-07-14T20:26:15
Spectrometer Frequency 499.64
Spectral Width 8000.0
Nucleus 1H
Acquired Size 24000
Spectral Size 65536
11a
S144
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
f1 (ppm)
1.
08
8.
01
1.
06
2.
99
4.
16
3.
63
1.
03
2.
63
0.
26
2.
17
2.
15
1.
00
0.
82
0.
86
0.
95
1.
33
1.
57
1.
91
2.
01
2.
11
2.
32
3.
76
4.
09
4.
56
Parameter Value
Data File Name JYS-2-200-F1-NaOH-tbu-cy-bromide/ 1/ ﬁd
Title JYS-2-200-F1-NaOH-tbu-cy-bromide.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-14T18:49:47
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
11b
7.4:1	dr
0.810.820.830.840.850.860.870.880.89
f1 (ppm)
1.
08
8.
01
0.
82
0.
86
S145
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
23
.9
25
.9
27
.6
31
.2
32
.6
41
.4
41
.5
47
.6
67
.1
76
.6
10
2.
3
Parameter Value
Data File Name JYS-2-200-F1-NaOH-tbu-cy-bromide/ 2/ ﬁd
Title JYS-2-200-F1-NaOH-tbu-cy-bromide.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 87.8
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-14T19:20:18
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
11b
7.4:1	dr
S146
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
1.
89
2.
04
2.
00
2.
14
1.
89
4.
21
5.
28
1.
69
2.
31
2.
64
3.
28
3.
35
7.
09
7.
26
11c
Parameter Value
Data File Name cycloheptyl-bn-bromide-JYS-2-62-A-F1/ 1/ ﬁd
Title JYS-2-62-A-F1-cycloheptyl-bn-bromide.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 8.7000
Acquisition Time 4.0894
Acquisition Date 2017-12-19T20:40:06
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
S147
-100102030405060708090100110120130140150160170180190200
ppm
32
.6
41
.9
54
.2
80
.3
12
6.
5
12
7.
1
12
8.
0
12
9.
1
13
1.
5
13
6.
4
14
2.
3
11c
Parameter Value
Data File Name cycloheptyl-bn-bromide-JYS-2-62-A-F1/ 2/ ﬁd
Title JYS-2-62-A-F1-cycloheptyl-bn-bromide.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 197.4
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-12-19T21:09:40
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S148
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
3.
68
6.
82
1.
32
3.
75
0.
33
1.
08
1.
42
3.
21
0.
11
0.
10
1.
00
0.
85
0.
93
1.
25
1.
48
1.
66
1.
76
1.
89
2.
01
2.
76
4.
37
4.
50
11d
10:1	dr
Parameter Value
Data File Name isomenthyl-bromide-JYS-2-64-F1/ 1/ ﬁd
Title JYS-2-64-F1-isomenthyl-bromide.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 55.5
Relaxation Delay 1.0000
Pulse Width 8.7000
Acquisition Time 4.0894
Acquisition Date 2017-12-19T21:13:46
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
4.14.24.34.44.54.64.7
ppm
0.
10
1.
00
4.
37
4.
50
S149
-100102030405060708090100110120130140150160170180190200
ppm
18
.3
19
.8
21
.1
21
.2
28
.5
28
.9
30
.4
41
.9
50
.2
57
.4
11d
10:1	dr
Parameter Value
Data File Name isomenthyl-bromide-JYS-2-64-F1/ 2/ ﬁd
Title JYS-2-64-F1-isomenthyl-bromide.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 197.4
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2017-12-19T21:43:20
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S150
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5
ppm
2.
79
2.
61
3.
27
2.
34
1.
01
9.
99
1.
24
3.
28
2.
71
6.
32
1.
00
1.
75
0.
11
0.
11
0.
02
0.
78
0.
78
0.
88
0.
94
1.
10
1.
19
1.
22
1.
31
1.
42
1.
63
1.
97
4.
07
4.
56
4.
83
5.
42
1.271.291.311.331.351.371.39
ppm
A (dd)
1.34
B (d)
1.30
1.
00
7.
67
1.
27
1.
31
1.
31
1.
32
1.
37
1.
37
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-28-1/ 1/ ﬁd
Title DCG-6-28-1.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 30.3
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-14T20:52:23
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
12a																											SI-24
SI-25
7.7:1	dr89	:	2	:	9	ratio
S151
-100102030405060708090100110120130140150160170180190200210
ppm
15
.3
1
18
.5
4
20
.3
4
20
.4
5
21
.6
1
22
.3
8
22
.6
4
24
.3
9
27
.3
9
33
.3
8
33
.4
0
33
.5
4
38
.6
7
38
.7
7
38
.8
1
39
.5
6
40
.9
6
41
.1
7
41
.9
2
55
.3
4
55
.5
1
55
.8
2
55
.8
4
65
.5
7
65
.6
2
97
.6
9
99
.3
4
17
8.
76
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-28-1/ 3/ ﬁd
Title DCG-6-28-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 87.8
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-14T21:12:06
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
12a																											SI-24
SI-25
7.7:1	dr89	:	2	:	9	ratio
S152
-1.00.01.02.03.04.05.06.07.08.09.010.0
ppm
-10
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
pp
m
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-28-1/ 2/ ser
Title DCG-6-28-1.2.ser
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence hsqcedetgpsisp2.4
Experiment HSQC-EDITED
Number of Scans 2
Receiver Gain 197.4
Relaxation Delay 1.5000
Pulse Width 11.7000
Acquisition Time 0.2135
Acquisition Date 2018-05-14T20:53:40
Spectrometer Frequency (400.13, 100.62)
Spectral Width (4795.4, 16611.3)
Nucleus (1H, 13C)
Acquired Size (1024, 180)
Spectral Size (1024, 1024)
12a																				SI-24																	SI-25
7.7:1	dr
89	:	2	:	9	ratio
S153
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
ppm
0
1
2
3
4
5
6
7
8
9
pp
m
1.21.31.41.51.6
0.6
0.7
0.8
0.9
1.0
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-28-1/ 7/ ser
Title DCG-6-28-1.7.ser
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence noesygpphzs
Experiment NOESY
Number of Scans 4
Receiver Gain 28.2
Relaxation Delay 1.8000
Pulse Width 11.7000
Acquisition Time 0.2560
Acquisition Date 2018-05-22T13:58:44
Spectrometer Frequency (400.13, 400.13)
Spectral Width (4000.0, 4000.0)
Nucleus (1H, 1H)
Acquired Size (1024, 256)
Spectral Size (1024, 1024)
12a
7.7:1	dr
S154
0.01.02.03.04.05.06.07.08.09.010.011.0
ppm
-10
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
pp
m
1.11.21.31.41.5
94
96
98
100
102
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-28-1/ 5/ ser
Title DCG-6-28-1.5.ser
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence hmbcetgpl3nd
Experiment HMBC
Number of Scans 4
Receiver Gain 197.4
Relaxation Delay 2.0000
Pulse Width 11.7000
Acquisition Time 0.4260
Acquisition Date 2018-05-17T08:28:04
Spectrometer Frequency (400.13, 100.62)
Spectral Width (4807.7, 22321.4)
Nucleus (1H, 13C)
Acquired Size (2048, 256)
Spectral Size (2048, 1024)
12a																											SI-23
SI-24
7.7:1	dr89	:	2	:	9	ratio
12a																									
																														7.7:1	dr
S155
-200-190-180-170-160-150-140-130-120-110-100-90-80-70-60-50-40-30-20-10010
ppm
1.
00
9.
14
-1
57
.0
4
-1
18
.2
4
-119.0-118.5-118.0-117.5
ppm
-158.0-157.4-156.8
ppm
Parameter Value
Data File Name / Volumes/ data-1/ DCG-6-28-1-19F.ﬁd/ ﬁd
Origin Varian
Instrument vnmrs
Solvent CDCl3
Temperature 37.0
Experiment 1D
Probe OneNMR
Number of Scans 32
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 3.2333
Acquisition Time 0.7340
Acquisition Date 2018-05-14T22:07:33
Spectrometer Frequency 376.15
Spectral Width 89285.7
Lowest Frequency -76618.4
Nucleus 19F
12a																											SI-23
SI-24
7.7:1	dr89	:	2	:	9	ratio
S156
-130-128-126-124-122-120-118-116-114-112-110-108-106
ppm
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
pp
m
Parameter Value
Data File Name / Volumes/ data/ DCG-6-28-1-F-C-HSQC--118ppm.ﬁd/ ﬁd
Title DCG-6-28-1-F-C-HSQC--118ppm
Origin Varian
Solvent CDCl3
Temperature 50.0
Pulse Sequence HSQCAD
Experiment HSQC
Number of Scans 16
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 9.7000
Acquisition Time 0.1500
Acquisition Date 2018-05-22T15:33:22
Spectrometer Frequency (376.14, 100.54)
Spectral Width (9842.5, 20105.6)
Nucleus (19F, 13C)
Acquired Size (1476, 128)
Spectral Size (2048, 1024)
12a																											SI-23
SI-24
7.7:1	dr89	:	2	:	9	ratio
S157
-167-165-163-161-159-157-155-153-151-149-147-145-143
ppm
-10
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
pp
m
Parameter Value
Data File Name / Volumes/ data/ DCG-6-28-1-F-C-HSQC.ﬁd/ ﬁd
Title DCG-6-28-1-F-C-HSQC
Origin Varian
Solvent CDCl3
Temperature 50.0
Pulse Sequence HSQCAD
Experiment HSQC
Number of Scans 16
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 9.7000
Acquisition Time 0.1500
Acquisition Date 2018-05-18T22:00:49
Spectrometer Frequency (376.12, 100.54)
Spectral Width (9842.5, 20105.6)
Nucleus (19F, 13C)
Acquired Size (1476, 128)
Spectral Size (2048, 1024)
12a																											SI-23
SI-24
7.7:1	dr89	:	2	:	9	ratio
S158
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
6.
73
1.
73
1.
39
2.
95
0.
28
1.
63
3.
59
1.
97
1.
11
2.
00
1.
90
0.
76
0.
85
0.
97
1.
23
1.
34
1.
60
1.
70
1.
92
2.
07
3.
76
4.
09
4.
52
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-29-1/ 1/ ﬁd
Title DCG-6-29-1.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 72.0
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-14T20:27:06
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
12b
3:1
dr
S159
-100102030405060708090100110120130140150160170180190200210
ppm
22
.6
24
.7
24
.8
26
.0
27
.7
29
.0
29
.1
32
.6
35
.0
35
.2
35
.4
35
.6
36
.0
36
.2
47
.5
67
.1
94
.1
95
.8
10
2.
5
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-29-1/ 3/ ﬁd
Title DCG-6-29-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 128
Receiver Gain 64.2
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-14T20:46:53
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
12b
3:1
dr
S160
-190-180-170-160-150-140-130-120-110-100-90-80-70-60-50-40-30-20-100
ppm
3.
05
1.
00
-1
62
.0
3
-1
62
.0
1
-1
62
.0
0
-1
61
.9
8
-1
61
.9
7
-1
61
.9
5
-1
61
.9
5
-1
61
.9
2
-1
61
.9
0
-1
61
.8
7
-1
61
.8
4
-1
61
.8
3
-1
61
.8
2
-1
61
.8
1
-1
61
.7
9
-1
61
.7
7
-1
61
.7
7
-1
61
.7
4
-1
61
.7
2
-1
61
.7
1
-1
61
.7
1
-1
61
.6
8
-1
61
.6
7
-1
61
.6
7
-1
61
.6
6
-1
38
.3
5
-1
38
.3
2
-1
38
.2
9
-1
38
.2
6
-1
38
.2
2
-1
38
.1
9
-1
38
.1
6
-139.0-138.5-138.0-137.5
ppm
-162.6-162.2-161.8-161.4
ppm
Parameter Value
Data File Name / Volumes/ data/ DCG-6-29-1-19F.ﬁd/ ﬁd
Title DCG-6-29-1-19F
Origin Varian
Solvent CDCl3
Temperature 37.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 32
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 3.2333
Acquisition Time 0.7340
Acquisition Date 2018-05-14T22:03:20
Spectrometer Frequency 376.15
Spectral Width 89285.7
Nucleus 19F
Acquired Size 65536
Spectral Size 131072
12b
3:1
dr
S161
-162-160-158-156-154-152-150-148-146-144-142-140-138
ppm
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
pp
m
Parameter Value
Data File Name / Volumes/ data-1/ DCG-6-29-1-F-C-HSQC.ﬁd/ ﬁd
Title DCG-6-29-1-F-C-HSQC
Origin Varian
Solvent CDCl3
Temperature 37.0
Pulse Sequence HSQCAD
Experiment HSQC
Number of Scans 16
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 9.7000
Acquisition Time 0.1500
Acquisition Date 2018-05-16T22:11:52
Spectrometer Frequency (376.13, 100.54)
Spectral Width (9842.5, 20105.6)
Nucleus (19F, 13C)
Acquired Size (1476, 128)
Spectral Size (2048, 1024)
12b
3:1
dr
S162
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
5.
35
7.
24
6.
11
23
.3
6
2.
93
4.
10
4.
06
1.
19
0.
81
0.
93
1.
18
1.
35
1.
65
2.
05
3.
75
4.
10
4.
50
4.
52
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-36-A-1/ 1/ ﬁd
Title DCG-6-36-A-1.1.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.2
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 64.2
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-16T13:20:04
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
12c
1.25:1	dr
S163
-100102030405060708090100110120130140150160170180190200210
ppm
21
.2
6
21
.2
8
24
.8
1
24
.8
3
25
.2
2
25
.2
3
25
.9
3
25
.9
7
26
.2
1
26
.3
5
26
.4
8
26
.8
2
29
.8
1
29
.9
0
31
.4
3
31
.6
8
33
.7
6
33
.7
8
33
.8
0
34
.6
7
34
.6
8
34
.7
6
34
.9
9
37
.3
7
47
.7
0
47
.9
1
51
.9
4
52
.1
3
67
.0
5
96
.2
1
97
.7
8
97
.9
2
99
.5
0
10
2.
48
10
2.
66
Parameter Value
Data File Name / Volumes/ nmr/ DCG-6-36-A-1/ 3/ ﬁd
Title DCG-6-36-A-1.3.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 297.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 256
Receiver Gain 78.7
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-16T13:47:07
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
12c
1.25:1	dr
S164
-190-180-170-160-150-140-130-120-110-100-90-80-70-60-50-40-30-20-100
ppm
0.
80
1.
04
-1
67
.1
0
-1
67
.0
8
-1
67
.0
5
-1
67
.0
5
-1
67
.0
4
-1
67
.0
4
-1
67
.0
2
-1
66
.9
9
-1
66
.9
7
-1
66
.9
4
-1
66
.9
1
-1
66
.8
8
-1
66
.8
6
-1
66
.8
5
-1
46
.3
8
-1
46
.3
7
-1
46
.3
7
-1
46
.3
6
-1
46
.3
5
-1
46
.3
2
-1
46
.3
1
-1
46
.3
1
-1
46
.2
8
-1
46
.2
7
-1
46
.2
7
-1
46
.2
7
-1
46
.2
7
-1
46
.2
6
-1
46
.2
5
-1
46
.2
4
Parameter Value
Data File Name / Volumes/ data-1/ DCG-6-36-A-1-19F.ﬁd/ ﬁd
Title DCG-6-36-A-1-19F
Origin Varian
Solvent CDCl3
Temperature 37.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 16
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 3.2333
Acquisition Time 0.7340
Acquisition Date 2018-05-16T12:45:55
Spectrometer Frequency 376.15
Spectral Width 89285.7
Nucleus 19F
Acquired Size 65536
Spectral Size 131072
-148.0-147.0-146.0-145.0
ppm
-169.0-168.0-167.0-166.0
ppm
12c
1.25:1	dr
S165
-169-167-165-163-161-159-157-155-153-151-149-147-145
ppm
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
pp
m
Parameter Value
Data File Name / Volumes/ data-1/ DCG-6-36-A-1-F-C-HSQC.ﬁd/ ﬁd
Title DCG-6-36-A-1-F-C-HSQC
Origin Varian
Solvent CDCl3
Temperature 37.0
Pulse Sequence HSQCAD
Experiment HSQC
Number of Scans 16
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 9.7000
Acquisition Time 0.1500
Acquisition Date 2018-05-16T21:14:03
Spectrometer Frequency (376.12, 100.54)
Spectral Width (9842.5, 20105.6)
Nucleus (19F, 13C)
Acquired Size (1476, 128)
Spectral Size (2048, 1024)
12c
1.25:1	dr
S166
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0
ppm
9.
05
1.
23
3.
45
0.
49
1.
69
1.
31
1.
27
1.
00
0.
90
0.
07
0.
89
0.
91
0.
92
1.
24
1.
44
1.
58
1.
72
1.
82
1.
97
4.
63
4.
76
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-302-1/ 2/ ﬁd
Title DCG-5-302-1.2.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zg30
Experiment 1D
Number of Scans 16
Receiver Gain 127.1
Relaxation Delay 1.0000
Pulse Width 11.7000
Acquisition Time 4.0894
Acquisition Date 2018-05-04T15:14:50
Spectrometer Frequency 400.13
Spectral Width 8012.8
Nucleus 1H
Acquired Size 32768
Spectral Size 65536
12d
10.7:1	dr
S167
-100102030405060708090100110120130140150160170180190200210
ppm
19
.3
4
20
.5
0
20
.6
8
20
.7
3
20
.8
8
26
.4
1
26
.4
8
27
.6
5
27
.7
2
29
.9
9
30
.0
1
36
.8
5
37
.0
4
46
.9
5
47
.1
2
90
.7
1
92
.3
8
Parameter Value
Data File Name / Volumes/ nmr/ DCG-5-302-1/ 4/ ﬁd
Title DCG-5-302-1.4.ﬁd
Origin Bruker BioSpin GmbH
Solvent CDCl3
Temperature 295.1
Pulse Sequence zgpg30
Experiment 1D
Number of Scans 512
Receiver Gain 72.0
Relaxation Delay 2.0000
Pulse Width 10.0000
Acquisition Time 1.3631
Acquisition Date 2018-05-04T15:56:31
Spectrometer Frequency 100.62
Spectral Width 24038.5
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
12d
10.7:1	dr
S168
-200-190-180-170-160-150-140-130-120-110-100-90-80-70-60-50-40-30-20-100
ppm
-1
79
.8
3
-1
79
.8
3
-1
79
.8
0
-1
79
.7
7
-1
79
.7
6
-1
79
.7
3
-1
79
.7
0
-1
79
.6
7
-1
79
.6
4
-1
79
.6
4
-1
79
.6
3
-1
79
.6
3
-1
79
.6
2
-1
79
.6
0
-1
79
.5
7
Parameter Value
Data File Name / Volumes/ data-1/ DCG-5-302-1-19F.ﬁd/ ﬁd
Title DCG-5-302-1-19F
Origin Varian
Solvent CDCl3
Temperature 37.0
Pulse Sequence s2pul
Experiment 1D
Number of Scans 32
Receiver Gain 60
Relaxation Delay 1.0000
Pulse Width 3.2333
Acquisition Time 0.7340
Acquisition Date 2018-05-03T15:40:37
Spectrometer Frequency 376.15
Spectral Width 89285.7
Nucleus 19F
Acquired Size 65536
Spectral Size 131072
-182.0-181.0-180.0-179.0
ppm
12d
10.7:1	dr
S169
